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The quantitative measurement of structural alterations at the nanoscale level is important 
for understanding the physical states of weakly disordered optical mediums such as cells/tissues.  
Progress in certain diseases, such as cancer or abnormalities in the brain, is associated with the 
nanoscale structural alterations at basic building blocks of the cells/tissues. Elastic light 
scattering, especially at visible wavelengths range provides non-invasive ways to probe the 
cells/tissues up to nanoscale level. Therefore, a mesoscopic physics-based open light scattering 
technique with added finer focusing, partial wave spectroscopy (PWS), is developed to probe 
nanoscale changes. Then, molecular-specific light localization technique, a close scattering 
approach called inverse participation ratio (IPR) is proposed that is sensitive to nano to 
microstructural cell/tissue alterations.  
In this dissertation, we have introduced the further engineered PWS system with the finer 
focus for precise volume scattering and molecular-specific light localization IPR techniques. As 
an application of PWS, we first probe precise scattering volume in commercially available tissue 
microarrays (TMA) tissue samples to standardize the existing cancer diagnostic methods by 
distinguishing the cancer stages. We also apply the PWS technique to probe chemotherapy drug-
 
 
treated metastasizing cancer patients by xenografting prostate cancer cells using a mouse model 
and identify drug-sensitive and drug-resistance treatment cases. On the other hand, as an 
illustration of another mesoscopic physics-based molecular specific light localization technique, 
Confocal-IPR, we study the effects of a probiotic on chronic alcoholic mice brains by targeting 
the molecular specific alteration in glial cells, astrocytes and microglia, and chromatin of the 
brain cells through staining with appropriate dyes/proteins. Using structural disorder of IPR as a 
biomarker, the results show that probiotics in the presence of alcohol are beneficial and help 
overall brain health. Finally, a TEM-IPR study was performed using nanoscale resolution TEM 
imaging to support the optical IPR method by studying the anti-cancerous drug effect in ovarian 
cancer cells. The result shows that we can quantitatively measure the effect of anti-cancerous 
drugs in cancer treatment and the level of tumorigenicity far below the diffraction limit, and it 
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INTRODUCTION: MESOSCOPIC PHYSICS BASED SPECTROSCOPIC SYSTEMS 
Optical probing of tissue microarchitecture and cell nanoarchitecture could provide 
tremendous information which is important for both diagnostic and therapeutic purposes 
especially for deadly diseases like cancer. This is because the structural alterations are associated 
with the progress of these diseases that result in the rearrangement of the basic macromolecules 
in cells/tissues. With the progress of time, different biomedical optical techniques such as optical 
coherence tomography (OCT), Mie scattering, fluorescence spectroscopy, diffusion 
spectroscopy, Raman spectroscopy, elastic light scattering spectroscopy, etc. are in use and have 
shown promising success to probe weakly disordered optical medium such as cells/tissue 
architectural properties, to study/quantify abnormalities by probing the structural alterations [1–
10]. Among these techniques, elastic light scattering spectroscopy provides a non-invasive, 
prompt, and cost-effective tool that is sensitive enough to probe the cells/tissues structures. The 
photons scattered from any structure exhibits characteristics patterns based on scattering angle 
and wavelength to provide the signature properties of scatter’s shape, size, density, refractive 
index, etc. However, all these scattering methods: OCT, Mie scattering, fluorescence 
spectroscopy, diffusion spectroscopy are based on the bulk spatial structural changes in 
cells/tissues. Now, it is shown that probing the fluctuating part of the cells/tissues will provide 




Furthermore, the existing literature showed that the elastic back-scattering signal is 
extensively sensitive to the refractive index fluctuations and their alterations  [11]. Based on this 
sensitivity of the back-scattering light, we can probe the tissue nano to microarchitectures in a 
wide range of scales  [3,5,12–14]. In the conventional elastic scattering experiments, before the 
light exits tissue samples, it undergoes multiple scattering resulting in decreased sensitivity to 
probe nanoscale cells/tissue architecture. At the same time, it is shown that progression of cancer 
or any other abnormalities results in nano to submicron scale structural alterations in cells/tissues 
due to the rearrangement of macromolecules  [15–18]. However, the sensitivity of existing light 
scattering techniques to probe refractive index fluctuations reduces significantly when the size of 
the scattering structure falls below the scattering light wavelength (~500nm). The resolution of 
conventional microscopy is ranged around 0.5m which is way below the size of 
macromolecules  [11]. On the other hand, confocal microscopy and single-molecule localization 
microscopy which are sensitive up to 200nm to 10nm are highly dyed dependent. Likewise, we 
can probe samples up to 1 A0 or a fraction of nm using a transmission electron microscope 
(TEM) which requires complicated sample preparation and has huge and expensive setups. Since 
the measurement of sub-wavelength refractive index fluctuation discloses the tremendous 
information useful in diagnosis and therapies and has a significant interest in recent days. Here, 
we apply mesoscopic light transport theory  [19–21]. Using this, we can probe change in the 
refractive index fluctuations of any length scale below the wavelength within the diffraction limit 
if: (i) the object is weakly disordered and scattering medium, and (ii) analyze the multiple 
interferences of 1D reflected signal within the object  [15,16]. Therefore, we combine 




imaging technique and probe change in the refractive index fluctuations that happen at a 
nanometer length scale. 
 In this dissertation, we have applied two different mesoscopic physics-based elastic 
scattering techniques: (i) partial wave spectroscopy (PWS)-an open scattering approach and (ii) 
inverse participation ratio (IPR)-a closed scattering approach. These techniques are capable of 
probing changes in cells/tissue nano to microarchitecture and quantifies the statistical properties 
of nanoscale refractive index fluctuations  [15–17,22,23]. The recently developed and further 
engineering added finer focusing PWS can probe precise scattering volume in tissue and 
sensitive enough to detect the microarchitecture in tissue microarrays (TMA) and anti-cancerous 
drug-treated xenografted tumors. And, molecular specific light localization technique, IPR, using 
transmission electron microscopy (TEM) and confocal images enables us to detect of nano to 
submicron scales structural alterations in cell and their components to quantify cancer, drug-
effect in cancer treatment, and probiotic effect in the treatment of alcoholic’s brain.  
 In this introductory section, we will describe the instrumentation and mesoscopic 
formulations for the PWS and IPR techniques. Then we will describe the samples that we have 
probed using these techniques. Furthermore, to support the optical experiments, we have also 
performed experiments using nanoscale sensitive TEM imaging, describe in short. 
1.1 Partial wave spectroscopy (PWS) optical technique 
Elastic light scattering spectroscopy is a very powerful and commonly used technique to 
probe cells/tissue architecture [5,10]. The spatial variation of the concentration of intracellular 
components in cells such as DNA, RNA, lipids, etc. due to diseases or cancer results in changes 




these macromolecular components falls below the diffraction limit of the existing optical 
imaging technique which is 200nm. Therefore, in partial wave spectroscopy (PWS) we combine 
mesoscopic physics with the imaging technique to probe the spatial refractive index fluctuations 
in the weakly disordered medium, within the diffraction limit. PWS technique records 1D 
backscattered signal in the far-field from cells/tissues and quantifies the refractive index 
fluctuations at sub-diffraction length scale. According to the mesoscopic light transport 
theory  [19,20,24–26], the 1D reflected signal is the multiple references of light waves reflected 
from reflective index fluctuations, which is non-self-averaging for all length scales in a weak 
refractive index fluctuation  [24–27]. And the importance of a non-self-averaging system is the 
standard deviation and mean of a relative parameter increases with the increase in system size, 
with full interference prominence. That means the reflected signal is sensitive to refractive index 
fluctuations at any length scale even below the wavelength range  [28–31]. This, therefore, 
provides an opportunity to probe cell nanoarchitecture by characterizing 1D backscattered light 
wave which is the most sensitive way. The experimental setup and theoretical details of the PWS 
setup are explained below.  
1.1.1 Partial wave spectroscopy (PWS) instrumentation 
The developed finer focusing experimental setup for the partial wave spectroscopy 
system in the Bionanophotonics laboratory in the Department of Physics and Astronomy at MSU 
is as shown in fig. 1.1. A spatially low coherence broadband white light source (Xenon lamp, 
150W, Newport) is used to illuminate thin samples using Kohler Illumination. The white light is 
reflected by a silver coated mirror (2 inches, Thorlabs) towards the 4f combination of the 





Figure 1.1 The schematic diagram of the finer focusing PWS system. 
Experimental layout of the Partial Wave Spectroscopy (PWS) setup with nanoscale sensitivity. 
The green color represents broadband white light from the source and the red color after the 
dichroic mirror is the backscattered signal. The collimated beams from the 4f combination of 
lenses are focused on the sample using a highly sensitive motorized XYZ stage. Backscattered 
signals are recorded in CCD passing through the liquid crystal tunable filter.  
converging lenses along with the apertures (2inches, Newport) helps to minimize the diffraction 
effect and preserve the high-frequency effect to enhances the sharpness of an image. The 
collimated light is reflected by a right-angle prism (1 inch, Thorlabs) towards 40X objectives 
(NA = 0.65, Newport) and focuses on the sample. A finer focusing is important to scatter the 
precise volume of the sample. A highly sensitive 3D electronic motorized stage (X-Y axis 40nm 
and Z-axis 100nm, Zebar Tech.) is used to focus the sample within the working distance of the 




revolutionary to the microscopic setup for its extreme accuracy and finer focus. A finer focus is 
essential for correctly defining the effective scattering volume/length of a sample. The 1D 
backscattered signal from the sample is reflected towards the thick collecting lenses (3 inches, 
Thorlabs) by a 50:50 dichroic mirror (1 inch, Thorlabs). The collected backscattered signal is 
then recorded in a CCD camera (1460×1920, Retiga 3) after filtering the signal through a liquid 
crystal tunable filter i.e. LCTF (KURIOS-WB1, Thorlabs) in the visible range of light. The 
LCTF has a resolution of 1 nm in the wavelength range of 420 nm to 730 nm. Here, the CCD 
camera and LCTF are coupled together with the LCTF controller in such a way that for every 
wavelength signal filter by the LCTF in the visible range of light the backscattered signals are 
recorded by the CCD camera. Finally, all 1D backscattered signals from the sample are recorded 
in the CCD camera as a 3D data matrix I(x,y,) for the PWS analysis. 
1.1.2 Theoretical model using the mesoscopic physics-based approach  
The recorded backscattered intensity I(x,y,) are further analyzed to calculate the 
fluctuating component, R(x,y,) of backscattered spectra arises from the interference of photons 
reflected from refractive index fluctuations of a scattering object. Unlike the conventional light 
scattering experiments where a scattering signal is formed by the interference of all waves 
propagating within scattering particles in the far-field, in PWS backscattered spectrum analyzed 
is formed by a subset of waves propagating in 1D. Low spatial coherence, high spectral 
resolution, weak refractive index fluctuations, and small radius of curvature within the medium 
are the conditions in which light propagates through a complex 3D structure and can be 
approximated as a combination of several spatially independent parallel 1D channels, with less 




negligible and can be further prevented by low coherence illumination. The flow chart of how 
the PWS technique works is presented in the following figure.  
 
Figure 1.2 The schematic of PWS data acquisition from thin samples. 
Each pixel of the image is treated as an individual channel and the refractive index fluctuations 
are recorded throughout the thickness of the sample (L). And hence, the degree of structural 
disorder is quantified for every pixel of the image. 
As mentioned, PWS expresses a 3D disordered medium into different parallel and 
spatially independent 1D channels, acquiring the fluctuating components as R(k), where k is 
obtained from the interference of light wave propagating in 1D backscattered channels (k=2π/λ). 
For each pixel (x,y), the variance of the refractive index fluctuation (n) is computed as 
sqrt(n2). And k is computed from the intensity vs wavelength measurement of I(k) at each pixel 





Figure 1.3  The 3D data acquired for PWS analysis. 
Scanning the wavelength in the visible range of light from 430 to 720nm 3D spectroscopic data 
cube is recorded where XY represents the frame of the image(camera) and Z is the wavelength in 
the visible range using PWS microscopy. 
filter to obtained R(k). Further, variation in light source spectrum, instrumental artifact, sample 
roughness, etc. are filtered-out fitting with a low order polynomial Ip(k) to I(k). Finally, the 
fluctuating part of the reflection coefficient is obtained as R(k)= I(k)- Ip(k). Now the question is 
how the fluctuating component R(k) is related to the properties of samples like average refractive 
index (n0), sample thickness or length of light penetration in the medium (L), the variance, and 
the correlation length of the refractive index fluctuation (<n2> and lc).   
In a weakly disorder scattering medium i.e. R<<1, for every length scale the probability 
density distribution of R follows a lognormal distribution. Thus, for length L the ensemble 












Since average refractive index for biological cells/tissues is n0 = 1.38 we assume that 4k
2LdL/n0
2 










2 , (1.2) 
In a regime with the valid 1D independent channel, R(k) can be characterized using 1D 
mesoscopic light transport theory  [19–21], and the root mean square average of R(k) can be 
written as: 
⟨𝑅⟩ = 𝐿𝜉−1, 
(1.3) 
Where 𝜉−1 is the scattering coefficient of the 1D channel simplified for klc<< 1:  𝜉−1 
2𝑘2𝐿𝑑𝐿/𝑛0




2 ). (1.4) 
To eliminate L, and only use intrinsic properties of the sample, we introduce an 






Based on mesoscopic theory, ⟨𝐶(𝛥𝑘)⟩ can be expanded as  [19]: 
⟨𝐶(𝛥𝑘)⟩   𝑒𝑥𝑝(−(𝛥𝑘)2𝑓(𝐿𝑑) 𝐿). (1.6) 
Where 𝑓(𝐿𝑑) is a slowly varying function for realistic values of the disorder strength which may 
be considered as constant for a range of k, and  is a constant with a unit of length. Thus,  

















Hence, for slowly varying functions knowing ⟨𝑅⟩ and 𝐶⟨𝛥𝑘⟩ for each channel in the sample one 








Where B is a calibration constant determined experimentally, k is the wavenumber (k=2/)and 
(𝛥𝑘)2/𝑙𝑛⟨𝐶(𝛥𝑘)⟩ is obtained by performing a linear fit of 𝑙𝑛⟨𝐶(𝛥𝑘)⟩ vs (𝛥𝑘)2. 
For the Gaussian color noise of the refractive index at position r and r’, then spatial 
correlation is defined as: <dn(r)dn’(r’)> = dn2 exp(-|r-r’|/lc), it can be shown that Ld=<𝛥n2>lc. 
Thus, the disorder strength quantifies the variability of the local density of intracellular material 
within the samples, and hence the average and standard deviation of the Ld is calculated to 
characterize the structural abnormalities of the system. 
1.1.3 Applications of the finer focusing PWS technique on cancer tissue samples 
As applications of the developed nanoscale sensitive PWS system, we first quantify the 
nanoscale changes in mass density or refractive index fluctuations using commercially available 
TMA tissue samples in progressive cancer. Then we employ this sensitive technique to probe the 
refractive index fluctuations in 3D tumor structure grown from 2D drug-sensitive and drug-
resistant prostate cancer cells using a xenograft model, to differentiate the difference in structural 
changes in 2D and 3D growths. Following are the details. 
In chapter II, we use the developed highly sensitive PWS technique to quantify the 
nanoscale refractive index fluctuations using commercially available paraffin-embedded tissue 




and possible application in the future to study drug effect in cancer treatment. Recently the use of 
these scientific TMA tissue samples has gained research interest in diagnosing different diseases 
and drug-effect in treatment since they allow high throughput analysis and are easily accessible. 
Fractal dimension study of TMA sample shows that fractal dimension increases with the increase 
in cancer stages. Also, cancer is an epidemic worldwide, early, and accurate detection, as well as 
the study of drug effects in cancer treatment, are always in demand. Therefore, in this study, we 
mainly focused on deadly cancer tissue samples such as pancreatic, prostate, breast, and colon 
cancer TMAs containing multiple cores of different stages for each cancer. These are analyzed 
using the PWS technique and the degree of disorder strengths Ld were quantified and 
distinguished the stages of cancer successfully. The promising application of the TMA-PWS 
technique will be explored in detail. 
In chapter III, we are mainly interested to study the structural properties of the tumor 
tissues that are developed from drug-sensitive and drug-resistive prostate cancer cells inside the 
body using the PWS technique. Other than cancer detection, the effects of cancer drug treatment 
are also an important field in cancer study. One of the questions addressed here is to see the 
difference between the 2D and 3D growth structures in cancerous cells for detection/estimation 
of cancer by cell/tissue cultures. At this point, a PWS study of the drug-sensitive and drug-
resistive prostate cancer cell lines 2D model showed that drug-resistive cancer cells have higher 
structural disorders relative to drug-sensitive cancer cells, at the single-cell level. In this chapter, 
using a further engineered PWS, we characterize tumor 3D structure developed from the 
docetaxel chemotherapy drug-sensitive and drug-resistant different prostate cancer cells by a 




slides to 3D tissues in xenografting technique. The result obtained is important and hence, the 
potential applications of the technique to access chemo drug effectiveness in the treatment of 
human cancer patients will be discussed. 
1.2 Inverse participation ratio (IPR) photonics technique 
Light localization arises due to the interference of light waves within the optical 
disordered medium. In condensed matter physics, the light localization method which we defined 
as the inverse participation ratio (IPR) technique has been well studied for characterizing the 
degree of disorder of homogeneous and heterogeneous media in a single parameter  [32–34]. 
Further, quantification of light localization in weakly disordered optical disorder mediums such 
as polymers, thin dielectric films, cells, and tissues, etc. is a major interest of research to 
characterize the degree of structural disorder of that medium. The characterization of these 
optical disordered mediums using standard methods is more complicated if the system involves 
spatial heterogeneity involving many kinds of spatial correlation decay length scales within the 
sample like cells/tissues  [35,36]. In the present day, significant research has been performed in 
quantifying structural disorders of cells/tissues by analyzing the light transportation and 
localization properties  [15–17,22,23,37]. This research has shown that analysis of light 
localization properties of cells/tissue is a useful technique to understand the intramolecular 
tumorigenicity levels, by probing their structural disorder. The light localization technique was 
explored to study nano to submicron scale structural disorder in cells/tissues with a potential 
application in cancer diagnostics  [22]. Consequently, this novel approach of using mesoscopic 
physics-based optical localization analysis  [28,32,33], to understand disease processes in 




that the degree of structural disorder in heterogeneous biological samples can be quantified as a 
single mixed parameter via IPR analysis of the light wavefunctions of these systems. In a weakly 
disorder system, the degree of structural disorder relates to the mass density or refractive index 
fluctuation which is linearly proportional to the IPR value of the system  [32,33]. In this 
technique, transmission electron microscopy (TEM) or confocal fluorescence microscopy 
micrographs are used to construct optical lattices from the sample which represents 2D refractive 
index map corresponding to the spatial mass density distribution of specific molecule within the 
cell; subsequently light localization properties were analyzed  [22,23,38]. Last few decades the 
disorder analysis of the optical media has been well studied using light localization 
properties  [28–30,32,33,39]. In a closed disordered optical medium, the light wave 
eigenfunctions are localized due to the multiple interference effects within the disordered 
sample. The main length scale associated with the problem, in IPR technique is the localization 
length or the scattering mean free path, which is related to the physical properties of the system, 
refractive index fluctuations and its correlation. Light localization effect is strong in 1D and 2D 
systems and the average IPR value of uniform lattice in 2D is universal number ~2.5, but the 
value increases with an increase in degree of disorder of the lattices  [32].  
1.2.1 Confocal microscopy imaging 
Confocal laser scanning microscopy is a powerful optical imaging technique that offers 
significant advantages over conventional microscopy to view the biological samples with high 
optical resolution and contrast of a micrograph  [40–42]. In laser scanning microscopy the 
specimen is scanned by the diffraction-limited spot of laser and the light reflected by the in-focus 




pinhole to block out-of-focus light to form an image, on the image plane. Confocal microscopy 
enables capturing of multiple 2D backscattered photons at different depths of a sample and 
constructs a 3D structure. Therefore, the ability to control the depth of field, eliminate or reduce 
information from the focal plane, and collect serial optical sections of thick samples has 
enhanced advantages in optical microscopy. The fluorescence emitted by the molecule from a 
small volume around the excitation center is collected by the objective into the photodetector 
using a spatial pinhole. The schematic of how the confocal microscopy work is presented in the 
following Fig. 1.4.   
As shown in Fig 1.4, confocal microscopy consists of the laser source, scanning mirror or 
dichroic mirror, objective lens, pinholes, and a detector. The backscattered signals from the 
samples are collected by the objectives and recorded into a detector through a confocal pinhole 
that blocks the out-of-focus light. Thus, confocal pinhole rejects out-of-focus light resulting in 
high optical resolution and contrast image and have made confocal microscope a powerful 






Figure 1.4 A schematic ray diagram of confocal microscopy.  
Schematic ray diagram based on the principle of recently developed laser scanning confocal 
microscopy. In confocal imaging, samples are treated with different dyes/proteins targeting 
different cells/components of the cells using different excitation sources.    
1.2.2 Transmission electron microscopy (TEM) imaging 
Transmission electron microscopy uses de Broglie wavelength of electrons from a 
micrograph that has a significantly higher resolution than any existing fluorescence microscopy. 
In TEM microscopy high-energy electrons (80-200kev) are transmitted through electron 
transparent samples (~100nm thickness) and probe up to ~1nm to identify the nanoscale 
architectural alterations inside the cells due to progressive cancer or any other abnormalities. 




image. The image is magnified and focused onto an imaging device known as a fluorescent 
screen. Hence, TEM and scanning TEM techniques can provide imaging, diffraction, and 
spectroscopic information with an atomic or sub-nanometer spatial resolution and contribute a 
major analytical tool in the physical, biological, and chemical sciences  [43–45].   
The schematic diagram for the TEM micrograph formation is shown in Fig. 1.5. In brief, 
TEM components include electron source, condenser lenses, objective lens system, intermediate 
or projector lenses, and a detector. They produced high energy and coherence electron source 
necessary for diffraction pattern is passed through condenser lenses which control the spot size 
and illumination area of the specimen. An objective lens system is used to images the specimen 
and intermediate or projector lenses change the modes from diffraction to imaging. Finally, 
highly sensitive and low quantum efficiency detectors of various configurations are used to 





Figure 1.5 A schematic ray diagram of transmission electron microscopy (TEM). 
Schematic ray diagram of TEM in image mode where electron beam passes through the thin 
sample to produce micrograph in fluorescent screen. Therefore, a TEM micrograph can represent 
the mass density of the thin cell sample.  
1.2.3 The theoretical model for analysis of confocal/TEM micrograph using mesoscopic 
light localization approach 
The optical lattices of cells/tissues are constructed using TEM or Confocal micrograph to 
study the molecular specific light localization properties. It is found that optical refractive index 
n(x,y) is linearly proportional to the local density ρ(x,y) of intercellular macromolecules such as 




n(x,y)=n0 + dn(x,y), where n0 is the average and dn(x,y) is the fluctuation of refractive index at 
(x,y) [22,23]. In the case of the thin sample, a voxel of area dxdy the transmission or scattered 
intensity: I(x,y) = I0exp(-dz/z0); or I(x,y) I0(1-dz/z0)= I0 - I0d(z), where  is a constant 
depends on the mass of voxel. That means, image intensity at any voxel point (x,y) for a thin 
sample dxdy defined as I(x,y) given by I(x,y) = I0+ dI(x,y), where I0 is the average pixel intensity 
and dI(x,y) is the fluctuation part of the pixel intensity. The fluctuation of intensity dI(x,y) is less 
than the average intensity I0: I0=<I(x,y)>(x,y) and dI(x,y)=I(x,y) - <I(x,y)>(x,y). Similarly, the 
fluctuation of refractive index dn(x,y) is less than the average refractive index n0. 
We assume that image intensity is linearly proportional to the total mass present in the 
thin cell voxel. Therefore, it is observed that (i) image intensity I(x,y) is linearly proportional to 
the mass density of the voxel M(x,y), and (ii) the refractive index of the voxel n(x,y) is 
proportional to the mass density M(x,y), then we can write: 
𝐼(𝑥, 𝑦) ∝ 𝑀(𝑥, 𝑦)  ∝ 𝑛(𝑥, 𝑦), (1.10) 
𝐼0 + 𝑑𝐼(𝑥,𝑦)  ∝  𝑀0 + 𝑑𝑀(𝑥, 𝑦)  ∝  𝑛0 + 𝑑𝑛(𝑥, 𝑦). (1.11) 
Consequently, it can be shown that the effective(average) optical potential or optical 










The schematic of the disorder optical lattices of size LL of TEM/Confocal image where 
each dot in the optical lattice is determined from the pixel intensity values in recorded images as 





Figure 1.6 Construction of a disorder optical lattices from TEM/Confocal micrograph.  
A typical example of z-stack confocal micrographs from which one micrograph is selected and 
optical/refractive lattices are constructed for a small close region.   
Tight-binding model: To quantify the disorder properties of TEM or Confocal images, 
Anderson disorder tight-binding model (TBM) calculation was employed. The TBM is a good 
model for describing single-optical states of the system of any geometry and disorder  [28–30], 
where the Hamiltonian is defined as: 
𝐻 = ∑ |𝑖 >< 𝑖|𝑖 + 𝑡 ∑ (|𝑖 >< 𝑗| +⟨𝑖𝑗⟩ |𝑗 >< 𝑖|) , (1.13) 
where |i> and |j> are the optical wave function or eigenvectors at i-th and j-th lattice sites, <ij> 
indicates the nearest neighbors, εi(x,y) or simply εi is the i-th lattice site optical potential energy 
and t is the overlap integral between sites i and j. The eigenfunctions (Ei’s) can be obtained by 
diagonalizing above the Hamiltonian. For a sample length L in the image, we have L×L sample 
area. The average IPR at sample length L is calculated where L=NL×dx (dx=dy). Since there are 
N=NL×NL numbers of lattice points, thus, there will be N eigenvalues and the same number of 
eigenvectors. Now substituting the value of εi in Hamiltonian and solving for average IPR value 
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Where Ei is the i-th eigenfunction of the above Hamiltonian equation of optical lattices of size 
L×L, and N is the total number of potential points on the refractive index matrix (i.e., 
N=(L/dx)2). That means if there is LL sample length or N number of image pixels, this will 
provide one pixel of the IPR image of length L, as <IPR(L)>LL. 
It has been shown that the ensemble average of IPR value i.e. averaged of similar type of 
cells: <<IPR(L)>>=<<IPR(L)>L×L> or (<IPR(L)>, is proportional to the degree of structural 
disorder Ld=dn×lc, where dn is the std of all n(x,y) point of cell samples/ensemble and lc is the 
spatial correlation decay length of the average n(x,y) over the sample  [22,23]. Thus, 
⟨⟨𝐼𝑃𝑅(𝐿)⟩⟩ =  ⟨⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿⟩𝑐𝑒𝑙𝑙 ∼  𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐, (1.16) 
𝜎(⟨𝐼𝑃𝑅(𝐿)⟩) =  𝜎(⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿)𝑐𝑒𝑙𝑙 ∼  𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐. (1.17) 
The < 𝐼𝑃𝑅(𝐿) >𝐿×𝐿is the average value of one IPR pixel of length (L) constructed from 
the L×L area of the TEM or Confocal image. After this, statistical analysis involves calculating 
the average and standard deviation of the disorder strength of IPR values, i.e. Ld values over the 
cell for the length of a given sample. Using this structural disorder strength <<IPR(L)>> or 
(<IPR(L)>) or Ld as a biomarker, we quantify the nanoscale structural abnormalities in 
cells/tissues due to cancer or any other abnormalities. A typical schematic of the steps involved 
in the quantification of structural disorder to study the drug effect in cancer treatment using a 





Figure 1.7 Schematic flowchart for calculating and comparing the <IPR> using TEM images. 
In summary, the main steps involved in the calculation of <IPR> using a TEM micrograph are 
presented in the schematic flowchart.  
1.2.4 Steps involved in the IPR calculation 
In brief, we want to summarize the steps involved in the calculation of IPR explained in 
above Section 1.2.3. Fig. 1.7 roughly shows the steps involved in the calculation of the average 
or std of IPR and IPR images from the confocal or TEM micrograph. However, the steps 
involved in the IPR calculation can help you better understand how we quantify disorder strength 
(Ld) using the IPR technique and confocal or TEM micrograph: 
Step I: Confocal or TEM micrographs are collected from the cells/tissues. 
Step II: Using the pixel intensity values of the micrographs, a pixel intensity was obtained in the 
form of a matrix as: I(x,y) = <I0> + dI(x,y). 
Step III: Based on pixel intensity matrix of micrograph optical refractive index lattices/matrix is 
obtained which correspond to the one-to-one micrograph pixel intensity expressed as: dn(x,y)/n0 





every point in the optical lattice is defined as optical potential represented by ε(x,y) = dn(x,y)/ n0. 
Now the micrograph intensities are replaced by the optical potential matrix which in turn 
represents the refractive index or mass density fluctuation of the sample. Hence the optical lattice 
depicts the refractive index variation of the 2D plane to calculate the disorder strength inside the 
sample. 
Step IV: Now if 2D lattices have M×M pixels with the pixel size a, then the total pixel size of 
the 2D micrograph is Ma×Ma. For instance, we choose a small sample size L×L, with m×m 
optical lattice points with L = ma (M>m). Applying Anderson Tight Binding Model on this 
sample size using optical lattice we will calculate the eigenfunction Ei of the small close system.   
Step V: Once the eigenfunction of the close system L×L is obtained we calculate the <IPR>L×L 
using the equation (1.15). Here it represents the unit block or the IPR pixel of the IPR image. 
That means we repeat this process throughout the micrograph and the distribution of <IPR>L×L is 
obtained, which is represented in the IPR image. For Ma×Ma confocal 2D micrograph Ma/m × 
Ma/m IPR pixels are constructed.  
Lastly, the ensembled average or standard deviation of <IPR>L×L is obtained from 
<IPR> distribution of IPR image at L×L by averaging or calculating std of all micrographs of 
the cells/tissues for the particular case study as <IPR(L)>= <<IPR>L×L > or σ(<IPR>) = 
σ(<IPR>L×L).  
1.2.5 Applications of confocal-IPR and TEM-IPR techniques 
IPR is a very powerful technique to quantify the molecular-specific disorder present in 
the weakly disorder optical medium based on the light localization on the closed system and has 




confocal and TEM imaging to quantify nano to submicron scale mass density or refractive index 
fluctuations to study probiotic effects in chronic alcoholic brain cells and anti-cancerous drug 
effect in ovarian cancer cells using a mouse model.  
In chapter IV, using a confocal-IPR technique we will quantify the molecular specific 
structural alteration in glial cells and chromatin of the alcoholic brain cells and study the 
probiotic, Lactobacillus Plantarum treatment on chronic alcoholic brain cells/tissues at the 
submicron level. Previously, confocal imaging using IPR has shown tremendous success in 
distinguishing cancer stages now we want to explore its applications in determining brain 
abnormalities. Based on the close scattering technique, we probe overexpression of astrocyte and 
microglial cells, and chromatin structures of brain cells, and quantify the molecular-specific 
overexpression by staining the cells with appropriate dye/proteins and calculating the degree of 
spatial molecular mass density structural disorder (Ld). Our technique has successfully detected 
the effect of the probiotic in alcoholic brain cells and components. The potential application of 
this novel approach to diagnosing the alcohol effect and probiotic treatment in the alcoholic brain 
is explored. 
In chapter V, combing the IPR technique with TEM images we quantify the efficacy of 
the anti-cancerous drug treatment in ovarian cancer treatment using a mouse model. Here, we 
also want to know how the IPR technique is useful with nanoscale resolution, especially in 
cancerous cells. The TEM imaging on thin cell, sections are performed to obtain their nanoscale 
structures up to 1 nm. Therefore, using TEM-IPR we can probe up to a few nanometers to 
quantify the structural alterations of tumorigenic cells and anti-cancerous drug-treated 




interesting and support that the effect of anti-cancerous drugs in cancer treatment can be 
quantified by using the degree of nanoscale fluctuations of the cells via TEM imaging. Potential 
applications of the TEM-IPR technique for cancer treatment are also discussed. 
Lastly, in chapter VI, conclusions of the close and open scattering spectroscopic 
techniques PWS and IPR, respectively are presented and their near-future applications are 
explored in detail.     
1.2.6 Advantages of PWS and IPR techniques over the existing other spectroscopic 
scattering technique 
Despite the tremendous achievement in the development of different biomedical optical 
techniques such as optical coherence tomography (OCT), fluorescence spectroscopy, diffusion 
spectroscopy, coherence enhanced backscattering, etc. [1–10,48] the optical sensing of the 
nanoscale structure remains an open problem due to the fundamental principles of diffraction-
limited resolution. These techniques are mainly based on the change in the scattering signal 
when the bulk properties of a sample are changed (n(x)=n0+dn(x), <n(x)>=n0). In the case of 
cancer detection, these methods are useful in the later stages of cancer when there is a prominent 
change in the bulk properties. But it is recently proven that fluctuations (dn(x)) part of the 
refractive index are more sensitive and vital information about the system even when the bulk 
properties do not change. By using nonlinear techniques, spatial-frequency evanescent waves, 
metamaterial-based lenses, and grating assisted tomography have enhanced a resolving power 
beyond the diffraction of a light [49,50]; however, the super-resolution is confined to the 
transverse plane which limits its ability to characterize sub-diffraction structure in 3D [51,52] 
and allows only the spatial distribution of particular molecular species. This demands the 




microscopy techniques to characterize the endogenous properties of the medium based on the 
spectral content of diffraction-limited microscopic images such as PWS. The PWS and IPR 
technique is pioneering in probing the fluctuation part of the RI to probe the physical state of 
cells or tissues. The theory behind the PWS technique involves strong assumptions that 1D 
backscattered signals are sensitive to refractive index fluctuations at any length scale including 
far below the wavelength range [11]. Using both open (PWS) and close (IPR) scattering we 
probe the particular structure in a weakly disordered medium in terms of the refractive index 
fluctuations where 1D scattered signals are sensitive to any length scale. The important aspect of 
these mesoscopic physics-based PWS and IPR techniques is a quantification of the Ld parameter 
which linearly depends on lc for klc< 1. Thus, in principle, there is no limitation on the minimum 
correlation length that can be assessed by the means of spectral analysis of 1D propagating 
photon. In practice, the sensitivity of lc is limited by the signal-to-noise ratio and other technical 
parameters. That means the sensitivity of these spectroscopic techniques is not limited by 
fundamental physical limits. Besides this advantage, PWS is simple, cost-effective, fast, and 
portable, on the other hand, the IPR technique is simple, effective, and robust to probe inner 




OPTICAL DETECTION OF CANCER STAGES VIA PWS USING TISSUE MICROARRAYS 
(TMA) SAMPLES 
This chapter is adapted from the author’s published article with copyright permission 
from the publishers. Ref [61] P.Adhikari, F. Alharthi, and P. Pradhan, “Partial Wave 
Spectroscopy Detection of Cancer Stages using Tissue Microarrays (TMA) Samples,” in 
Frontiers in Optics + Laser Science APS/DLS (2019), Paper JW4A.89, OSA 2019; and    
Ref [94] P. Adhikari, and P. Pradhan, “Optical detection of cancer stages via partial wave 
spectroscopy using tissue microarrays (TMA) samples”. arXive 2012.14194, 2020.  
The developed finer focusing added mesoscopic physics-based imaging technique, PWS 
can probe the precise scattering volume in cells/tissue to detect changes in refractive index 
fluctuation with the progression of cancer. Here, we employ this highly sensitive PWS technique 
to quantify the nanoscale refractive index fluctuations using commercially available paraffin-
embedded TMA samples with the goal of the standardized early and accurate detection of stages 
of different cancers. The uses of scientific TMA samples have gained research interest in 
diagnosing different diseases and drug treatment since they are commercially accessible. Mainly, 
deadly cancer such as pancreatic, prostate, breast, and colon cancer TMAs containing multiple 
cores of different stages for each cancer are analyzed using the PWS technique and the degree of 
disorder strength (Ld) was quantified. The potential application of the developed TMA-PWS 
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technique to enhance and standardize early and accurate cancer diagnosis modalities are 
discussed.  
2.1 Introduction 
The optical detection of structural changes in biopsy samples due to progressive cancer 
has achieved tremendous success in detecting the stages of cancer when developed into a 
tumor  [53]. The standard pathological method of detection of cancer stages includes 
microscopic examination of the morphological changes using stained biopsy samples. However, 
due to the diffraction-limited resolution of conventional microscopy, the structural alterations in 
healthy tissue before the development of a tumor or early stages are still a mystery. These 
structural alterations of healthy cells/tissue are due to the rearranging of macromolecules such as 
DNA, RNA, lipids, etc. whose size ranges from 100-200 nm. It is recognized that genetic and 
epigenetic alterations occur not only at the neoplastic focus but more diffusely in the field of 
cancerization. The abnormalities are present in the tissue surrounding the cancerous region or 
transformed cell primary tumor due to field cancerization  [54,55], which are initially at the 
nanoscale level before tumor formation and migration. This effect is observed in almost every 
type of cancer that is diagnosed in the later stages with less survival rates. Therefore, a highly 
sensitive optical method to detect such structural abnormalities before the development of a 
tumor for all cancer is paramount for decreasing lethality  [56]. With the progress of time, 
several microscopic imaging techniques were employed, and regardless of their drawbacks, 
significant success was achieved  [57]. Unfortunately, most of these methods are still not 
sensitive enough to probe the nanoscale structural changes. In light of this scenario, the versatile 
approach of using recently developed PWS to probe change in the refractive index fluctuations in 
commercially available tissue microarray (TMA) samples could standardize the cancer 
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diagnostic modalities. The recently developed finer focusing PWS technique is sensitive enough 
to probe nanoscale refractive index fluctuation in paraffin-embedded TMA samples. The PWS 
combines interdisciplinary approaches of mesoscopic physics and optical imaging techniques to 
quantify the degree of disorder strength (Ld) based on the change in refractive index fluctuations 
within the cells/tissue  [15–17,58]. The backscattered signal at any point within a weakly 
disordered medium contains the spectral fluctuations which are proportional to the local density 
of macromolecules or refractive index fluctuations, in fact, independent of chemical 
composition. Thus, once the refractive index fluctuations of the medium are known, the spatial 
variations of macromolecular density can be measured using the disorder strength (Ld) measure 
as Ld =<dn
2>lc, where <dn
2> is the square of rms and lc is the correlation length of the refractive 
index fluctuations  [16,17]. This potential biomarker, the Ld parameter has shown tremendous 
success in distinguishing stages of cancer, drug-effect in cancer treatment, and quantifying any 
other type of abnormalities in the brain  [17,58–61]. In addition to this, structural alterations in 
biological cells/tissue due to cancer or any other abnormalities are quantified using mesoscopic 
physics-based molecular specific light localization technique in terms of the degree of disorder 
strength  [23,38,62–64].  
 With the availability of such a powerful approach to quantify the nanoscale structural 
alterations in cancerous tissue, the next challenge was in the use of an almost identical tissue 
sample that allows high-throughput analysis to standardize diagnostic techniques. For this, the 
recently developed commercially available TMAs have been used which significantly facilitate 
and accelerates tissue analyses using a highly sensitive PWS technique. The TMA is a scientific 
form of condensed histopathology where the tissues are kept in a single glass slide to provide a 
miniature multiplex platform for the analysis of ~10 to ~200 tissue samples  [65]. Multiple cores 
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of paraffin-embedded tissue in a TMA allow high-throughput assessment of macromolecules in 
PWS analysis that standardize the diagnostic technique reducing the variability seen on the assay 
of individual samples. This uniformity of assay has reduced the drawbacks in specimen handling 
and their impact on data acquisition  [66]. Besides these facts, TMA samples are easily 
accessible to perform any scientific experiments which require more than one similar sample. 
Also, we believe the use of the PWS technique in the TMA sample could be a new direction to 
explore to study the drug effect in cancer or any other abnormalities that are in demand. This can 
be noted that we want to probe change in RI fluctuations in tissue samples that are embedded in 
paraffin. 
 In this chapter, we will analyze four different deadly cancer TMA samples: pancreatic, 
breast, colon, and prostate, and generalize the efficacy of developed finer focusing PWS to 
detect the cancer stages. Cancer is a common disease and with no surprise, these four different 
cancers are the major cause of death in the U.S. Because of lethality, prevalence, and almost no 
prominent physical change or symptoms until the later stages. We focus on studying the 
nanoscale structural changes in these cancerous tissues by quantifying the degree of structural 
disorder (Ld) as a potential biomarker. In this sense, we explored the potential possibilities of the 
PWS technique in TMAs for the early stage of cancer detection.    
2.2 Methods 
2.2.1 Experimental development of the PWS 
The engineered finer focusing PWS system used to probe the precise scattering volume 
developed in the Bionanophonics laboratory is as shown in Fig. 2.1. The experimental details of 
the PWS setup are presented in Chapter I Section 1.1.2 [58–60,67]. We will present a 3D view of 
the PWS system presented in Chapter I. In brief, the developed PWS system consists of a low 
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coherence broadband stable white light source Xenon lamp which is reflected toward the 4f 
combination of lenses by a mirror and gets collimated. Collimated beams are reflected towards 
the objectives and focus on the sample with the help of a highly sensitive XYZ motorized 
scanning stage (XY-axis 40nm and Z-axis 100nm). Then, the backscattered signal from the 
sample is directed towards the CCD camera through the liquid crystal tunable filter (LCTF) with 
the help of a dichroic mirror. Here, LCTF is coupled with a CCD camera in a way that for every 
wavelength in the visible range, images are recorded in the CCD camera for the PWS analysis.   
 
Figure 2.1 The 3D schematic of further engineered finer focusing PWS system. 
The schematic 3D layout of the finer focusing partial wave spectroscopy (PWS) system was 
developed in the Bionanophotonic laboratory. The collimated beam (green color) from the 
broadband stable white light source (Xe lamp) is focused on the sample and the backscattered 
signal (red color) from the sample is collected using the CCD camera for PWS analysis.  
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2.2.2 Calculation of the disorder strength (Ld) 
In the PWS technique, the backscattered spectrum of a weakly disorder medium is 
recorded in the visible range of light to quantify the degree of disorder strength (Ld) based on the 
refractive index fluctuations (n) within the cells/tissue. It is shown that at each pixel position 
(x,y) within the cell, the refractive index (n) is proportional to the local mass density and 
practically independent of chemical composition at that point. Therefore, the spatial variation of 
macromolecular mass density at every pixel position can be expressed in terms of refractive 
index fluctuations, assuming that these random fluctuations are within a correlation length (lc). 
The recorded backscattered spectrum R(x, y; ), is the interference between the intercellular 
volume scattering and reflection from the surface of the sample. That means the measured 
spectra from each pixel of an image is a 1D weakly disordered medium that acts as a subset of 
the scattered waves.    
The step-wise quantification of backscattered signals using the PWS technique is shown 
in Chapter I Section 1.1.2. In 1D weakly disorder medium, the probability density distribution of 
reflectance fluctuations R, follows a log-normal distribution for all the sample length scale L, 
reflected from the scattering medium. As mentioned, PWS collects the backscattered signals 
propagating along the 1D trajectories since in a quasi-1D approximation the sample is virtually 
divided into many parallel channels within the diffraction-limited transverse size. Then, by 
applying mesoscopic light transport theory and making use of refractive index fluctuations, the 
degree of disorder strength is calculated. In particular, the rms value of the reflection intensity 
<R(k)>rms and the spectral auto-correlation of the reflection intensity C(Δk) for a given pixel at 
position (x,y), are combined to define the degree of disorder strength as [16,17,68] discussed in 















Where B is the normalization constant, n0 is the average refractive index of the weakly 
disordered medium, k is the wavenumber (k = 2/), and (Δk)2/ln(C(Δk)) is obtained by 
performing a linear fit of ln(C(Δk)) vs (Δk)2. 
2.2.3 Tissue microarrays (TMA) samples 
TMA is a rapidly growing commercially available tissue sample that consists of generally 
numerous different cases of 5μm thick tissue cores in diameter 1.5mm placed on the same glass 
slide for simultaneous analysis. These paraffin-embedded TMA samples allow the high-
throughput analysis of tissue samples since different cases of samples have exact experimental 
conditions and batches of reagents. TMAs are therefore scientific, cost-efficient, and offer an 
unprecedented degree of standardization for the conduction of an experiment such as optical 
imaging  [69]. 
Here, using the PWS, we quantify the structural properties of paraffin-embedded TMAs 
from US Biomax of the pancreas (T142b), breast (BR248a), colon (T054c), and prostate (T191a) 
cancer samples, due to progressive carcinogenesis. Each TMA consists of different cores of 
normal, stage I, stage II, and stage III cancer tissue samples. Different cores of each TMAs are 
from individual patients of varying ages and sex. However, for each stage of each cancer, at least 




2.3 PWS result of structural disorder and discussions  
To develop a standardized diagnostic clinical research test for early and effective 
detection of cancer stages of varying types of the deadliest cancers, the structural alterations 
were quantified using a finer focusing PWS technique of TMAs. Here, the degree of disorder 
strength (Ld) for different stages of pancreatic, breast, colon, and prostate cancer TMAs were 
computed and compared. The results show that structural alterations increase with the 
progression of cancer stages in each type of progressive cancer. Since the disorder strength (Ld) 
is the product of the variance and spatial correlation length of the refractive index fluctuations, 
these results indicate that the progression of cancer increases more mass 
rearrangement/accumulations in the tissue results in increasing the refractive index spatial 
fluctuations increasing the Ld. In addition to the earlier findings, this work explores the 
application of the developed, highly sensitive PWS technique to detect the nanoscale fluctuations 
in paraffin-embedded TMA tissue samples of four different deadly cancers. 
 For each type of cancer TMAs: pancreatic, breast, colon, and prostate tissue 
spectroscopic images were recorded in the visible range (450-700nm) of light from three 
different cores of the same type. From each core tissue sample, at least 5 different realizations 
were made for the PWS analysis. Using this powerful spectroscopic technique, the pixel-wise 
refractive index fluctuations of tissue were computed and first represented in the 2D Ld 
map/image, averaged over the depth of the sample. Then, the ensemble average and standard 
deviation (std) of the disorder strength (Ld) were computed and presented in a bar graph for all 
cancerous TMAs studied.  
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2.3.1 Pancreatic cancer (PC) TMA samples 
Pancreatic cancer is a lethal condition worldwide due to poor outcomes and a rising 
incidence rate. It is the 3rd leading cause of cancer deaths in the US common in both men and 
women and often presents at an advanced stage which contributes to a poor five-year survival 
rate [70]. Because of its physical orientation and lack of early symptoms, a better understanding 
of the symptoms associated with PC and its risk factor is essential to both health professionals 
and individuals.  Therefore, we focus our research with added finer focusing on the existing 
PWS technique for the early diagnosis and to understand the structural properties of pancreatic 
tissue with progressive carcinogenesis using TMA tissue samples. The results show that mass 
density or refractive index fluctuations increase with the increase in the PC stage.  Fig 2.2. (a)-
(b) and (a’)-(b’) are the representative bright-field and their corresponding Ld images of normal 
and stage III PC tissue. The Ld map, which is a 2D image average along the z-axis represents the 
refractive index fluctuations at that point. The Ld map shows stage III pancreatic cancer sample 
has more red spots which indicate higher refractive index fluctuations in the color map. Further, 
the average and std of the degree of disorder strength were calculated and represented in the bar 
graph, Fig. 2.2. (c)-(d). Both the average and std of Ld value increase from normal, to stage I, 
stage II, stage III with a significant difference (Students t-test p-values<0.001). This result, 
therefore, suggests that the developed finer focusing PWS technique is sensitive enough to detect 
nanoscale changes in refractive index fluctuation and to distinguish the different stages of cancer 




Figure 2.2 PWS study of pancreatic cancer TMA samples. 
(a) and (b) are the representative bright-field images of normal and stage III PC TMA tissue 
while (a’) and (b’) are their corresponding L
d 
images. (c) and (d) are the bar graph representation 
of the average and std of disorder strength (L
d
) for normal and different stages of PC TMA. The 
PWS analysis of TMA tissues shows that both the average and std of L
d
 value increase from the 
normal to higher stages of PC. In reference to the normal, the std of L
d
 value of cancer stage I is 




2.3.2 Breast cancer (BC) TMA samples 
Breast cancer is the most common cancer in women and a challenging cause of cancer 
death in the world. This metastatic cancer is transferable to different organs such as the bones, 
lungs, liver, and brain with almost incurability. Early diagnosis of BC is only the best method of 
prevention. Although the five-year relative survival rate of an early detected BC patient is more 
than 80% nowadays, oncologists and scientists are still struggling to develop a technique that can 
identify early symptoms and distinguish the nanoscale structural changes in breast cancer 
cells/tissue  [71]. BC is the second leading cause of cancer death in women in the US. In the 
existing scenario, the finer focusing PWS technique was applied to characterize the structural 
properties of BC TMAs tissue at the nanoscale level due to progressive carcinogenesis. The 
result shows that the structural disorder (Ld) increases from the normal to stage III significantly 
as shown in Fig. 2.3. The representative Ld images Fig. 2.3. (a’)-(b’) for normal and stage III 
cancer were presented which shows that the refractive index or mass density fluctuations are 
higher in stage III BC. Also, the average and std of Ld value increase significantly from stage I, 
stage II, to stage III about the normal with Student’s t-test p-values < 0.001 as represented in Fig. 
2.3 (c)-(d). This increase in the degree of disordered strength due to progressive carcinogenesis 
indicates that the refractive index fluctuations increase with the stages of cancer which was 







Figure 2.3 PWS study of breast cancer TMA samples. 
(a) and (b) are the bright-field images while (a’) and (b’) are the L
d 
images of the normal and 
stage III BC of TMA tissue, respectively. (c) and (d) are the bar graphs of average and std of 
disorder strength (L
d
)for the normal and different stages of BC TMA samples. The PWS result 
using TMA tissue shows that both the average and std of L
d
 value increases from normal to 
higher stages of cancer tissue. In reference to the normal, the std of L
d
 value of cancer stage I is 







2.3.3 Colon cancer (CC) TMA samples 
Colorectal cancer is predominant cancer accounting for approximately 10% of all cancer 
mortality in the world. Colorectal cancer is the 3rd leading cause of cancer-related death in men 
and women in the US. Population aging, improper dietary habits, smoking, low physical activity, 
and obesity are the main reasons for annually increasing metastatic CC cases [72,73]. Until 
modern times, laparoscopy surgery has played a vital role in controlling or treatment for primary 
and metastatic colorectal cancer. Despite advances in surgical and medical therapies, the long 
survival rate of colorectal patients has changed very little in recent times. This demands 
standardization in screening or imaging techniques to detect the early stages of CC. Therefore, to 
understand the structural changes in cells/tissue at the nanoscale level due to progressive CC we 
apply the PWS technique to distinguish different stages of CC TMAs tissues. The averages and 
std of the degree of disorder strength (Ld) increase from the normal to stage III with a significant 
difference (Student’s t-test p-values<0.005). As cancer increases, mass density accumulation 
increases which in turn increases the change in refractive index fluctuations resulting in 
increased Ld value for higher cancer stages. In addition to this, the Ld images were also 
constructed to visualize how the refractive index fluctuations increase with the increase in cancer 
stages in colon TMAs as shown in Fig. 2.4. (a’)-(b’). The bar graphs show that the average and 
std of Ld value increases in stage I, stage II, and stage III cancer tissues compared to normal, and 







Figure 2.4 PWS study of colon cancer TMA samples. 
(a) and (b) are the bright-field images of the normal and stage III CC TMA tissue and (a’) and 
(b’) are their respective L
d 
Images. (c) and (d) bar graphs of the average and std of disorder 
strength (L
d
) for the normal and different stages of CC TMA samples. The PWS result of TMA 
tissue shows that the average and std of L
d
 value increases from normal to higher stages of colon 
cancer. In reference to the normal, the std of L
d
 value of cancer stage I is 23%, stage II is 32%, 





2.3.4  Prostate cancer (PC) TMA samples 
Prostate cancer is common cancer among men, especially elderly ones, and 1 in 9 men 
will have prostate cancer during their lifespan. Ceasing to smoke, proper exercise, and weight 
control are good health practices that may reduce the risk of developing PC. Although 
remarkable progress has been achieved on characterizing risk factors and identifying therapeutic 
options. Screening for and diagnosing the early stages of PC is still one of the most challenging 
issues across the globe in medicine  [74,75]. At this point, the study of structural properties of PC 
tissue at the nanoscale level using a precise volume scattering technique, PWS of TMA tissue 
could help to characterize the structural change in their stage. The results obtained using the 
PWS technique to study the commercially available prostate TMA is presented in Fig 2.5. The 
representative Ld images i.e. Fig. 2.5 (a’)-(b’) show that stage III Prostate cancer has more red 
spots in the color map because it has higher mass density or refractive index fluctuations than 
normal. To quantify the structural abnormalities, the average and std of the degree of disorder 
strength (L
d
) were computed and represented in the bar graph, as shown in Fig. 2.5 (c)-(d). As 
can be seen from the figure, both the average and std of Ld value increase in stage I, stage II, and 
stage III compared to normal. This increase in the Ld is due to the increase in refractive index 






Figure 2.5 PWS study of prostate cancer TMA samples. 
(a) and (b) are the representative bright-field images of the normal and stage III PC TMA tissue 
while (a’) and (b’) are their corresponding L
d 
images. (c) and (d) are bar graphs of the average 
and std of disorder strength (L
d
) for the normal and different stages of PC TMA samples. The 
PWS analysis of TMA tissue show both the average and std L
d
 value increases from the normal 
to higher stages of cancer tissue. In reference to the normal, the std L
d
 value of cancer stage I is 
32%, stage II is 46%, and stage III is 65% higher (Student’s t-test p-values < 0.001, n=15). 
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2.4  Conclusions 
In summary, as an alternative method in cancer diagnostic research of applying the 
mesoscopic physics-based PWS technique using commercially available TMAs has been reported. 
This technique makes the use of the recently developed finer focusing PWS technique which can 
scatter precise volume to detect the nanoscale structural changes in paraffin-embedded tissue and 
distinguishes the stages of four different cancer cases. To validate the purpose method, the degree 
of disorder strength (Ld) of different tissue with the progression of cancer stages of different TMAs 
are quantified. The PWS results obtained for some of the deadliest cancer TMAs: pancreatic, 
breast, colon, and prostate show that the average and std disorder strength (Ld) increases 
significantly as cancer progresses through the different stages. However, the more prominent 
changes were found in the std of the degree of Ld value for all case studies. The results obtained 
by the purposed method were following the earlier studies  [17,59] and therefore, the Ld parameter 
acts as a potential biomarker to distinguish and standardize the cancer stages which seems almost 
impractical. In addition to this, the use of the PWS technique and commercially available TMAs 
could provide easy and clinically accessible samples to study the drug effect in cancer treatment. 
In particular, this finding invites the research communities to work with a common goal to 
standardize early and accurate detection of the cancer stages of different types of deadly cancer 
cases. Further validation in distinguishing the stages of cancer of TMA tissue can be performed 
using other quantitative approaches such as fractal, IPR, etc.  [62,76,77]. Lastly, the flexibility 
provided using the spectroscopic technique such as PWS in commercially available TMA samples 
to distinguish the early to late stages of cancer cases opens a broad way to explore and generalize 






OPTICAL QUANTIFICATION OF STRUCTURAL PROPERTIES OF TUMOR TISSUES 
GENERATED BY XENOGRAFTING OF CANCER CELLS USING PWS  
This chapter is adapted from the author’s published article with copyright permission 
from the publisher. Ref. [53] P. Adhikari et. al., “Optical detection of the structural properties of 
tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using 
partial wave spectroscopy (PWS)”. Biomedical Optics Express, BOE. 2019 Dec 1;10(12):6422–
31. The PWS technique has been successfully used for the detection of cancer stages by probing 
nanoscale structural alterations in cells/tissues as discussed in Chapter II. However, the 
development of drug-resistant cancer cells/tissues during chemotherapy is a major challenge in 
cancer treatment, especially to know the drug is working or not. In this chapter, using a mouse 
model and developed PWS technique, the structural properties of tumor tissues grown in 3D 
structures by xenografting drug-resistant and drug-sensitive human prostate cancer cells having 
2D structures are studied. In particular, we probe the difference in the structural disorder of cells 
grows on 2D slides or cells grown in a 3D environment inside the body. This may provide us an 
indirect way to study the effects of drugs on the cancer cells/tissues. The promising aspect of the 
proposed study to establish insight into advancing the understanding of the physical state and 




Elastic light scattering, especially in the visible range of light, is an important method for 
probing structural morphologies of the biological cells/tissues. It is now shown that probing the 
structural alteration at the nano to submicron scales enables the prediction of several properties 
of the physical conditions of cells/tissues in normal and disease/abnormal states.  Recent studies 
have shown that the progression of carcinogenesis results in nanoscale structural alterations due 
to the rearrangement of the basic building blocks, in particular, macromolecular components 
inside the cells. These nanoscale structural alterations, in terms of the degree of disorder 
strength, have been shown as an important biomarker in the determination of cancer 
stages  [22,23].  However, the histopathological examinations of cells/tissues, conventionally, are 
based on a large degree of changes in the cellular architecture, mainly nuclear size, during the 
disease process  [78–81].  Also, the sensitivity of the existing pathological optical microscopic 
techniques used to detect such nanoscale alterations is restricted by the diffraction-limited 
resolution (>~200nm). 
 A recently introduced spectroscopic microscopy technique, partial wave spectroscopy 
(PWS), combines the interdisciplinary approaches of mesoscopic condensed matter physics and 
microscopic imaging, to quantify the degree of change of the nanoscale structural disorder of 
weakly disorder medium like biological cells/tissues  [15–17,59,60,67]. The statistical 
quantifications of the reflected intensities due to the nanoscale refractive index fluctuations of 
the biological cells/tissues are carried out using the PWS analysis. In the PWS technique, the 
backscattering signals from thin weakly disordered cell/tissue samples are divided into many 
parallel scattering quasi-one-dimensional reflections to calculate the structural disorder strength 
of the samples. Further, the spatial variation of the intracellular components such as DNA, RNA, 
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lipids, and extracellular matrices (ECM) gives rise to spatial mass density fluctuations in terms 
of the refractive index fluctuations of the cells/tissues. This spatial refractive index fluctuations 
can be quantified in terms of the degree of structural disorder.  The degree of structural disorder 
parameter Ld, called the disorder strength, can quantify nanoscale alterations and distinguish 
different cancer stages with higher accuracy. For a quasi-1D approximation, the disorder strength 
can be expressed as Ld =dn
2×lc, where dn is the standard deviation (std) of the onsite refractive 
index fluctuations dn(r) and lc is its spatial correlation length. The efficiency and application of 
the PWS technique in measuring nanoscale alterations,  i.e. the Ld parameter, to diagnose 
diseases like cancer has been developed and explored  [15,17,59,60,67,82]. The detection of 
molecular-specific structural disorder in submicron scales of control and cancer/abnormal cell 
nuclei are also studied by the light localization technique using confocal microscopy, which 
supports the increase in the molecular-specific structural disorder in progressive cancer  [38,83–
85].         
 After the diagnosis of cancer, the cancer patient generally goes through chemotherapy 
drug treatment. Resistance to cancer cells/tissues to chemotherapy drugs is one of the obstacles 
in cancer treatment. Recently, the PWS technique was successfully used to study the effect of 
chemotherapy drugs on prostate cancer cell lines and to quantitatively measure the structural 
disorder strength of drug-sensitive and drug-resistant prostate cancerous cells  [59]. The results 
show that the chemo-resistant cells have a higher degree of structural disorder than that of the 
chemo-sensitive cells. Drug-resistant cancerous cells are able to survive chemotherapy drug 
treatment, as the different mechanisms responsible for drug resistance and the development of 
different morphological structures. These different morphological structures in drug-resistant 
cancer cells may be due to the rearrangements of macromolecules, increase in the sizes of 
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membrane pores, architectural differences of the cytoskeletal network, etc., which result in 
increasing aggressiveness and the disorder strength. 
 Prostate cancer is one of the most prevalent types of cancer with one of the highest male 
mortality rates in the USA. The American Cancer Society (ACS) estimates about 174,650 new 
cases of prostate cancer will appear and account for a total of 31,620 deaths for 2019. Across the 
globe, the statistical data on prostate cancer suggests that among every 9 men, one individual 
will develop this cancer during his lifespan. Therefore, it is necessary to explore early and 
effective diagnosis and treatment methods for prostate cancer. At present, chemotherapy is the 
only way to treat metastasized prostate cancer, however, it is often found ineffective due to an 
individual patient’s chemo-resistance that leads to tumor progression  [59,86–90]. The PWS 
studies of cancer cell lines have shown some promising success in distinguishing the hierarchy 
and drug effectiveness based on the measurement of the biomarker, the structural disorder 
strength Ld  [59].   
 These PWS studies of drug resistance cells for different cell lines were mainly focused on 
cancer cells that were grown in 2D on glass slides. However, in reality, a metastasizing cancer 
cell grows into a tumor with a 3D structure when grown within the body, and these tumor cells 
may have different structural properties due to their grown 3D tissue structures. This leads to a 
demand for the development and quantitative characterization of 3D tumor tissues that are grown 
from drug-sensitive and drug-resistant cancer cells. This could establish a correlation between 
isolated cells of 2D structure which is grown into tissue in 3D structure, based on the structural 
disorder. In particular, we want to verify the structural properties of 3D tissues generated by 
xenografting of cancer cells, and to understand any relationship between the 3D tissue structures 
with their original 2D cell structures, using the Ld parameter. Human cancer cases have been 
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studied by innumerable murine methods and the determinants responsible for malignant 
transformation, invasion, and metastasis, as well as the examination of the response to therapy, is 
investigated with the aid of these murine models. Xenografting of human cancer cells in a mouse 
model is one of the most extensively used models to study the development of tumors from 
cells  [91,92]. Cancerous human cells were subcutaneously injected in immunocompromised 
mice. Based on the number of cells injected, the tumors will develop over 1-8 weeks and reaction 
to the proper therapeutic regimes can be studied in vivo  [91,93] or ex vivo. At the same time, the 
structural properties of growing xenografted cancer cells are not well studied.   
 In this work, using a further engineered PWS technique, we explore the structural 
properties of the 3D tumor tissues obtained by xenografting drug-sensitive and drug-resistant 
human prostate cancer cells’ 2D structure using a mouse model. We study structural properties 
of tissues obtained by xenografting two types of human prostate cancer (PC) cell lines, namely 
DU145 and PC3, whose drug-resistant and drug-sensitive structural properties were studied 
earlier by the PWS technique  [59]. From the results, a correlation between the 3D structural 
disorder of tissues originally grown from chemotherapy drug-sensitive and drug-resistance cells 
and the original cells will be performed. Finally, we will also discuss the potential applications of 
the technique in cancer diagnostics. 
3.2 Method 
3.2.1 PWS experimental setup 
We perform the structural disorder measurement using a recently developed partial wave 
spectroscopy (PWS) experimental technique, with added engineering of finer focusing as 
mentioned in Chapter I Section 2.1.1  [59,60,67]. The actual experimental PWS setup developed 
in the Bionophotonics laboratory is as shown in Fig.3.1.  It consists of a Xenon Lamp, a source 
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of stable broadband white light to illuminate tissue samples of micron thickness using Kohler 
Illumination. This collimated light from the 4f combination is focused on the sample through the 
objective. The use of a highly sensitive 3D electronic motorized stage (100nm on Z-axis and 
40nm on the X-Y axis) provides the finer focusing of the sample within the working distance of 
the objective. Then the backscattered signal gets reflected by a dichroic mirror towards the 
detector through a liquid crystal tunable filter (LCTF) coupled with CCD.  
 
Figure 3.1 Actual PWS experimental setup developed in Bionanophotonics laboratory, MSU. 
The table-top optical instrumentation of PWS setup. It consists of a board band white light 
source collimated through the 4f combination of the lenses. The nanoscale sensitive 3D 
motorized scanning stage is used for the precise focusing of the sample to capture the 
spectroscopic image using CCD.  
3.2.2 Calculation of the structural disorder or disorder strength (Ld) 
The backscattered images are recorded in the CCD camera at every wavelength () at the 
spatial pixel position (x,y) in the wavelength range 450-700nm, and the reflected data cube, R(x, 
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y; ), is acquired by the PWS system. In a quasi-1D approximation, the collected backscattered 
data at each (x,y) from R(x,y;) is fitted with a polynomial of the 5th order. The fitted polynomial 
is then extracted from the signal to remove the systematic errors. In the next step, the R(k) signal 
for each pixel position (x,y) is obtained after applying a 5th order low-pass Butterworth filter with 
a suitable normalized cutoff frequency to remove the high-frequency noise components from the 
reflected signals of micron size samples. Here, calibration of the system is done by matching the 
reflected intensity pattern using a non-disordered system, NIST-traceable microspheres with the 
reflected signal from a thin film slab model.  
The fluctuating part of reflection signals R(x,y;) arises due to the multiple interferences 
of the photons reflected from the disordered medium. Since in a quasi-1D approximation, the 
sample is virtually divided into many parallel channels within the diffraction-limited transverse 
size, and the backscattered signals propagating along the 1D trajectories are collected. The 
statistical properties of nanoarchitecture are quantified at the nanoscale level by analyzing the 
fluctuating part of the reflected intensities. The refractive index fluctuation information is 
collected from these spectral fluctuations originated from the multiple scattering of the sample at 
any length scale below the diffraction limit. The degree of structural disorder Ld can be derived 
from the rms value of the reflection intensity <R(k)>rms and the spectral auto-correlation decay of 
the reflection intensity C(k) ratio. That means, for a given pixel at position (x,y), the degree of 








where B is the normalization constant, n0 average refractive index of the biological cells, and k is 
the wavenumber (𝑘 = 2𝜋/𝜆). 
 
50 
Therefore, the disorder strength quantifies the variability of the local density of 
intracellular material within the samples, and hence the average and standard deviation of the Ld 
values are calculated to characterize the structure of the system. 
3.2.3 Sample preparation 
Freshly collected prostate cancer (PC) cells from two different cell lines were used to 
develop a prostate xenograft, mouse model. For the generation of tumor xenograft mouse 
models, 6–8 weeks old male nude mice were implanted with PC3 (docetaxel-sensitive and 
docetaxel-resistant) and DU145 (docetaxel-sensitive and docetaxel-resistant) human PC cell 
samples (2 × 106 cells per mice), by subcutaneously injections. After tumors reached beyond the 
critical size of 1000 mm3, they were excised from euthanized mice. The excised tumors were 
further paraffin-embedded and sectioned using microtome in 4μm thickness and placed on glass 
slides. Further, these slides were processed for the antigen retrieval process as described 
previously  [94]. The resultant tumor sections were subject to imaging studies.     
3.3 Results 
PWS detects the nanoscale structural alterations in the cells/tissues and can distinguish 
the different levels and effects of the drug in the tumorous cells/tissues  [16]. Among the 
different types of cancer, prostate cancer is a major concern of public health at present because 
of its low survival rate. Further, drug-resistant cancer cells are a prominent problem currently in 
cancer treatment. Therefore, we focus our research to characterize the structure of tumor tissues 
generated by the xenografting of chemotherapy drug-sensitive and drug-resistant prostate cell 
lines, DU145, and PC3. For this, human drug-sensitive and drug-resistant prostate cancer cells 
were subcutaneously injected into mice and allowed to grow and achieve a tumor size of 
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~1000mm3. After that, mice were euthanized, and tumors were excised then subsequently 
processed to 4 µm thick tumor sections on slides for PWS imaging analyses.  
 PWS experiments, as described earlier, were performed on xenografted prostate tumor 
tissues for each category on at least 3 different mice. All tumor tissue was obtained from 
different prostate cancer cell lines xenografted into mouse models. For each tissue sample, PWS 
experiments were performed on 7 different spots. In particular, for each category of a tumor, ~60 
different spots are experimented with PWS and analyzed. The spectroscopic PWS experiments 
are performed in the wavelength range 450-700nm. The backscattered data matrix R(x, y; ) are 
imported and the disorder strength for each tissue is calculated using the PWS technique as 
described in section 3.2. The disorder strength is calculated as the product of the variance and the 
spatial correlation length of the refractive index fluctuations. The average and standard deviation 
of the disorder strength for each category are calculated in order to understand the physical 
properties of a tumor developed as a 3D structure from a cell. The detailed PWS analysis of a 
tumor obtained from a xenografted model of drug-sensitive and drug-resistant cell lines DU145 
and PC3 are explained below:  
3.3.1 Structural disorder in the xenografted DU145 tumor tissue type 
In Fig. 3.2, the PWS analysis of tumor tissues obtained from xenografting drug-sensitive 
and drug-resistant prostate human cancer cell lines of DU145 type are shown.  From the PWS 
experiment R(x,y,) data matrixes were obtained. At every pixel point (x,y), R(k)rms value and 
corresponding C(k) were obtained, and from these two values, and the Ld value was calculated 
using Eq.(2.1). The bright-field images, as shown in Fig. 3.2(a)-(b), the thin tissue samples 
developed from drug-sensitive and drug-resistant cancer cell lines appear indistinguishable, 
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whereas the Ld images are noticeably distinguishable. The red spots in the Ld image represent a 
higher disorder strength, i.e. the Ld value of that pixel. It can be seen in the bar graphs that there 
is an increase in the degree of structural disorder of tumor tissue generated from xenografting 
drug-resistant cancer cells, compared to the tissues obtained from xenografting drug-sensitive 
cancer cells. The average Ld value of a tumor obtained from a drug-resistant cancer cell line is 
9% higher than the tumor obtained from a drug-sensitive cancer cell line and the standard 
deviation std(Ld) is 8% higher. This result is in strong agreement with the disorder strength 
calculated for drug-resistant and drug-sensitive cell lines earlier  [59]. The disorder strength of 
the prostate cancer cell line calculated using PWS has shown that the average and standard 
deviation of Ld value is higher in drug-resistant cells compared to the drug-sensitive for DU145 
type cells. The results confirm that the xenografted tissue structures also have similar trends to 





Figure 3.2 The structural abnormalities in tumor xenografted from DU145 cells lines. 
(a) and (b) are the bright-field images while (a’) and (b’) are the disorder strength or Ld 
images of tissue obtained by xenografting drug-sensitive and drug-resistant PC cells line of 
DU145 type respectively. (c) and (d) are the graphical representation of the mean and standard 
deviation of Ld of the xenografted tumor, respectively. Result shows a 9% higher mean Ld and 
8% increase in the std Ld in a tumor developed from drug-resistant PC DU145 type cells line 





3.3.2 Structural disorder in the xenografted PC3 tumor tissue type 
Fig 3.3 (a)-(b) shows the bright field and Ld images of tumor tissues originated from 
drug-sensitive and drug-resistant PC PC3 type cells. Based on the intrinsic properties of the 
tissue, the disorder strength Ld at each pixel of the individual tissue image is calculated and 
represented by 2D color maps. In the color map, red spots correspond to the higher structural 
disorder strength present in the thin tissue structure (averaged along the z-direction of the 
sample). The bar graphs, 3.3(c) and (d) are the representation of the average and standard 
deviation of Ld values with the standard error bars. The result shows a 12% difference in the 
average local disorder strength Ld and a 15% difference in the std (Ld), between tumors obtained 
from drug-sensitive and drug-resistant cell lines. The increment in the mean and standard 
deviation of Ld for tissues collected by the xenografting of drug-resistant PC PC3 cells compared 
to the drug-sensitive PC PC3 cells are consistent with the original cell structures. It is clear from 
the plots that the disorder strength increases from drug-sensitive to drug-resistant xenografted 
tumor tissues. Earlier results using PWS analysis show that PC PC3 cells are more aggressive 
than other cell lines and in the same way drug-resistant PC cell lines have higher disorder 
strength than drug-sensitive cells. Figs. 3.2 and 3.3 show the results obtained using xenografted 
tissue samples also have the same kind of disorder strength hierarchy as that of the original PC 
cells. In particular, a comparatively higher structural disorder strength Ld for tumors obtained 
from drug-resistant PC PC3 cell lines than PC DU145 cell lines are in strong agreement with 
their original PC cell line disorder strength. This confirms that the degree of disorder strength Ld 
can be used as a marker to detect the cancer stages or drug effects using 3D cancer tissue 




Figure 3.3 Structural abnormalities in tumor xenografted from PC3 cells lines. 
(a) and (b) are the bright-field images and (a’) and (b’) are the disorder strength or Ld images of 
tissues obtained by xenografting of drug-sensitive and drug-resistant PC cells line of PC3 type 
respectively. (c) and (d) are the bar graph representation of the mean and standard deviation of Ld 
of a tumor, respectively. Result shows a 12% higher mean Ld and 15% increase in the std Ld in 
tumors developed from drug-resistant PC PC3 type cells line than the drug-sensitive cells. P-






The results indicate that tumor tissues grown by xenografting of PC cells resistant to 
docetaxel have a higher disorder strength Ld than the same tissues from drug-sensitive PC cells. 
Since the disorder strength increases with the increase in the level of tumorigenicity, which 
implies chemotherapy-resistant cells are more aggressive than drug-sensitive cancerous cells. 
Cells from the prostate or any other cancerous region that survived through drug exposure are 
more aggressive and develop with the cell line’s hierarchy as PC3 > DU145  [59]. As an 
application of the developed finer focusing PWS technique, we have studied the structural 
alteration in the xenografted tissue morphology that is grown in a 3D environment from single 
cells that mainly have 2D structures. The results show metastasize isolated 2D cancer cells 
grown to 3D tumors in the body have similar structures and characteristics. The PWS analysis of 
3D tissue slices confirm xenografted tissues from drug-resistant tumors have a higher average 
and standard deviation of disorder strength (Ld) than the drug-sensitive counterparts. Also, the 
obtained results follow a similar hierarchy of the cell lines that are studied earlier, reported in 
ref [59].  
 Probable cause of structural properties of drug resistance cells/tissues and higher 
structural disorder (Ld): Studies have shown that the progress of cancer disturbs the regular 
growth as well as the structure of cells/tissues. Further, cells/tissues that survive through the 
chemotherapy adapt themselves to the situation and develop different morphological structures 
resulting in higher mass density fluctuation due to the rearrangement of macromolecules, larger 
pore sizes, changes in cytoskeleton nanoarchitecture, etc. This results in a higher structural 
alteration in drug-resistant PC cells than drug-sensitive ones. The different mechanisms such as 
tumor-derived exosomes biogenesis and composition, DNA and histone damage/repair, anti-
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cancerous multidrug inactivation, alteration in drug targets treatment, heterogeneity in cancerous 
cells/tissues, death inhibition of cells/tissue, epithelial-mesenchymal transition, and metastasis, 
etc.  [95–99] are making the cancerous cells/tissues drug-resistant  [59]. Xenografted tumor 
tissues that are obtained using cells from drug-resistant and drug-sensitive PC cell lines, main the 
same types of structural hierarchy properties when they are grown into 3D structures. This 
supports a strong correlation in structural properties in 2D and 3D structures.  
 Applications of the developed technique for cancer treatment: The PWS study of 
xenografted tissues obtained from drug-sensitive and drug-resistant PC cells line could establish 
a new insight into advancing the understanding of the physical state and drug effectiveness on 
cancerous cells/tissues at the nanoscale level, by knowing their structural properties. The 
xenografted tissue structure replicating the structural properties of cancer cells explained 
statistically in terms of the disorder strength Ld parameter could be a reliable, easy, and 
quantitative approach to diagnose chemoresistance. This result seeks the potential application to 
monitor the effect of chemotherapy drugs on cancerous tissues and to study the different levels 
of tumorigenicity which can be obtained both, in-vitro and in-vivo methods. In summary, this 
method will help in understanding the drug-resistant and drug-sensitive cells/tissues and their 





PHOTONICS TECHNIQUE TO QUANTIFY PROBIOTICS EFFECT ON CHRONIC 
ALCOHOLIC BRAIN CELLS VIA MOLECULAR-SPECIFIC CONFOCAL-IPR 
This chapter is adapted from the author’s published article with copyright permission 
from the publisher. Ref [58] P. Adhikari et al., “Photonics study of probiotics treatment on brain 
cells exposed to chronic alcoholism using molecular specific light localization properties via 
confocal imaging”. arXive. 1912.11777, 2019. And Ref [59] P. Adhikari, et al., "Quantification 
of light localization properties to study the effect of probiotic on chronic alcoholic brain cells via 
confocal imaging," in Imaging, Manipulation, and Analysis of Biomolecules, Cells, and 
Tissues XIX (SPIE), 2021, Vol. 11647, p. 1164716. 
Recently IPR technique using confocal images has shown success in distinguishing molecular-
specific structural alterations targeting DNA to quantify cancer, radiation effect, or any other 
abnormalities in cells/tissues [38,100]. The advantage of the IPR technique relative to the PWS 
technique is that we can probe structures of an isolated cell within the tissue without disturbing 
them by confocal imaging, which is not possible using the PWS technique. PWS technique 
provides statistical properties of the region averaged over light propagation direction and it 
cannot probe separately a cell that is situated inside the tissue. It was found that chronic 
alcoholism introduces abnormalities in brain cells/tissue that result in behavioral and 
psychological disorders. On the other hand, probiotics such as Lactobacillus Plantarum enhances 
brain functions in chronic alcoholism. Therefore, in this chapter, using the close scattering based 
 
59 
on light localization technique, IPR combined with confocal imaging we probe the molecular 
specific structural alterations present in chronic alcoholic brain cells with or without probiotic 
treatments in a mouse model. The potential application of this novel approach to diagnose the 
alcohol effect and probiotic treatment in the alcoholic brain is explored. 
4.1 Introduction 
Photons/light are an important probe for the characterization of the structural properties 
of biological cells. It is known that the structural properties of cells and tissues change with the 
progress of disease or abnormalities such as cancer, stress, drugs, etc. Cells and tissue are weakly 
disordered dielectric media; therefore, their structure and any change in the structural properties 
can be characterized using light, which happens at the length scale of micron size. The light 
probing is generally done by measuring the scattering signals and quantifying the optical 
parameters of the samples. Different types of structural changes can happen in a cell with the 
progression of diseases such as carcinogenesis or due to the effect of drugs  [23,22,58]. These 
changes in a cell may range from bulk structural change to nanoscale molecular-specific 
structural alterations. The nanoscale structural changes in cells and tissues due to diseases or 
abnormalities are associated with the molecular-specific structural alteration and, in turn, its 
mass density fluctuations. Recently, the refractive index fluctuations are experimentally 
measured to quantify the structural abnormalities in cells and tissues using the recently 
introduced mesoscopic physics-based sensitive imaging technique called, the 
PWS   [16,17,58,60,67,68,101]. Although the microscopic changes in a cell/nucleus have been 
studied for a long time by probing structural properties, however, these changes appear almost at 
the advanced stages of diseases or abnormalities, which would be too late for treatment. At the 
same point, the PWS technique can probe full structural changes of a cell or tissue, and it was 
 
60 
recognized that minuscule changes occur at the early stages of the diseases or abnormalities 
where the molecular specific nanoscale structural changes occur due to the rearrangements of the 
macromolecules present in a cell. Therefore, probing molecular-specific structural changes will 
be more efficient and important for the detection of abnormalities or disease progression in a 
cell. This is the primary interest of the present study. Therefore, we hypothesize that probing the 
molecular-specific structural changes can measure the physical state of cells/tissues and the 
organs. The concept of characterizing the molecular-specific structural alterations was 
introduced recently to quantify the nano to microscale changes in cells in abnormalities and has 
shown success in several studies  [22,23,61,83]. The initial case studies ranging from cancer to 
abnormalities in brain cells due to chronic alcoholism have shown promising results in the 
characterization of the physical state of the cell  [38,61,83,102].  
Alcohol-related disorders and organ-specific damage are significant global concerns. 
Alcohol and its metabolites play a significant role in neuroinflammation, however, the existing 
evidence indicates that interactions at the Gut-Microbiome-Brain axis are a crucial part of the 
alcohol-related behavioral disorder  [103,104]. Among the multidirectional alcohol interactions 
with the human body, initially, chronic alcoholism affects the brain from the cellular to the 
molecular level. It has been shown by TEM imaging that structural properties of the cells change 
in chronic alcoholism at the nanoscale level, and alterations are prominent at the length scales of 
~100nm, which is around the length scales of the building blocks of cells  [18]. Glial cells such 
as astrocytes and microglia, as well as the chromatin of the cell nuclei present in the cerebral 
cortex of the brain, which totals the vital portion of the central nervous system (CNS), are 
profoundly affected by chronic alcoholism. Chronic alcoholism can produce sustainable damage 
in the brain on different length scales. This structural damage can bring neuropathological 
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disorders such as memory loss and dysfunction of the brain resulting in cognitive and behavioral 
deficits  [105–107]. 
In the brain cells, the star-shaped astrocytes and microglia are the most abundant glial 
cells present in the CNS and mostly serve as a regulator of the CNS’s immunity and tissue 
transplantation. In the same way, chromatin in all brain cells plays an important role in genetic 
inheritance. In humans, it is reported that a single astrocyte interacts with two million neurons at 
a time  [108]. These astrocytes perform various tasks such as axon guidance, synoptic support, 
controlling blood flow, and blood-brain-barrier function. Along with regulating behavior, they 
play a vital role in neuroinflammation in both beneficial and detrimental ways depending on the 
stimuli they receive from their inflamed environment. Similarly, microglia act as the role of 
tissue macrophages which are involved in immune response, removing damaged neurons, tissue 
transplant, and other neurological mechanisms and diseases. However, alcohol is one of the most 
well-known adverse incentives for neuroinflammation. Pathogenesis of many CNS disorders and 
several neurodegenerative diseases are crucially caused by brain inflammation  [109]. This 
inflammation activates the glial cells, specifically the microglia and astrocyte, and liberates the 
free radicals, cytokines, and inflammatory mediators that can damage normal brain 
function  [110]. A recent study showed that alcohol treatment in the microglial cells and 
chromatin altered their morphology  [111]. 
In some cases, these structural alterations may be reversible to a good degree through 
different types of treatments. It was reported that probiotic treatment has a good effect on brain 
health. In particular, it can soothe human brains and reduce structural abnormalities in brain 
cells/tissue to a certain extent  [112,113]. Immunofluorescence results also show that probiotic 
treatment such as Lactobacillus Plantarum, when administered after a chronic alcohol-induced 
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injury can rescue the alcohol-induced systemic inflammation and neuroinflammation resulting in 
improving the physical state of human brains  [114]. L. Plantarum is a Gram-positive lactic acid 
bacterium present in fermented food and anaerobic plant matter which has ample applications in 
the medical and biomedical fields. In particular, L. Plantarum blocked alcohol-induced gut 
barrier dysfunction, endotoxemia, and liver damage which are directly associated with the well-
functioning of the brain  [115]. Therefore, we are using the recently developed mesoscopic 
physics-based light localization technique, IPR, which can quantify the molecular specific mass 
density fluctuations in cells/tissue as the degree of structural disorder due to diseases or any other 
abnormalities  [22,23,38,102]. In the IPR technique, an optical disordered refractive index matrix 
is constructed based on the pixel intensities via confocal imaging and solved for optical 
eigenvalues and the eigenfunctions using the closed boundary conditions. Based on the 
mesoscopic theory, these eigenfunctions are used to quantify the molecular specific light 
localization properties of samples, that can be represented by the average of IPR, <<IPR>>, and 
the standard deviation (std) of IPR, (<IPR>), of these eigenfunctions. The earlier IPR study 
results show that the degree of disorder strength i.e., Ld = <dn>×lc is proportional to <<IPR>> 
or (<IPR>)  [38,83]. This technique has been used to quantify the extent of aggressive cancer 
in biological cells, especially to detect the progress of carcinogenesis in drug 
treatment  [38,62,83]. Here, we want to extend this method to probe the molecular-specific 
spatial structural changes in brain cells and organelles to study the effect of probiotics in chronic 
alcoholism. 
In this work, using the IPR technique via confocal imaging, we report the effects of 
alcohol in glial cells, and molecular DNA/chromatin structure in nuclei of mice brain cells in the 
cortex region by probing molecular specific structural changes. Then, the effect of probiotic 
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treatment in the glial cells and nuclei of the brain cells for the following cases: control, only 
alcohol fed, only probiotic fed, and simultaneously alcohol and probiotic fed were studied to see 
the effect of probiotics on the chronic alcoholic brain, using a mouse model.  
4.2 Methods 
4.2.1 Molecular specific structural disorder via confocal imaging and IPR technique 
Confocal imaging is a technique that captures images with high optical contrast and 
resolution ranging in the submicron length scales. The confocal microscopy and its schematic are 
briefly explained in Chapter I Section 1.2.2. In confocal microscopy imaging, a spatial pinhole is 
used which blocks out-of-focus light to acquire a controlled depth of field and reduce 
background lights in images. For a confocal image, the amount of fluorophore dye that binds a 
molecular mass is proportional to the molecular mass density at any point or a small voxel. In 
general, dyes are independent of each other, and treating a cell with different molecular binding 
dyes at the same time and probing them with appropriate wavelengths can provide us the various 
molecular specific spatial structural mass density fluctuations in a cell using the IPR technique. 
The submicron scale mass density fluctuations are quantified by calculating the degree of 
structural disorders in confocal images using the IPR technique. In the IPR technique, an optical 
lattice is formed using the pixel intensities of the confocal images which represent the ‘mass 
density fluctuations’ that were scanned voxel-wise. Based on the light localization strength, the 
average IPR or the disorder strength is computed. A higher value of the <IPR> represents an 
increase in the mass density fluctuation in the cell or molecule. Henceforth, the average of 
<<IPR>> or (<IPR>) ultimately quantifies the degree of structural disorder in the medium. 
The theoretical model of the IPR technique has been reported earlier in Chapter I Section 
1.2.3 [22,23,38,62,83] in detail; however, in this chapter, we will describe the technique in short. 
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As mentioned in  [38,83], let us consider a pixel intensity I(x,y) of the confocal image at 
position r=(x,y) and ρ is the density of the molecule at voxel dV of the image is I(r)=dV(). 
It was shown in  [38,116] that the local refractive index of the cell slice is directly proportional to 
the local mass density of the cell at that point (x,y) which is directly proportional to the confocal 
image intensity at any voxel that point.  
The refractive index n(x,y) of thin scattering substances such as biological cells has a 
linear relation to the mass density  [116,117], and are correlated with the confocal image’s 
intensity, I(x,y), which is linearly proportional to the mass density, M(x,y), and refractive index, 
n(x,y), at the voxel as obtained in Section 1.2.3 equations (1.10, 1.11).  
From this, we obtain the optical potential as i(x,y) and construct a representative 
refractive index matrix using the pixel intensity value [30] given as Section 1.2.3 equation (1.12). 
The optical potential, 𝜀𝑖(𝑥, 𝑦) which is a representation of the spatial refractive index fluctuation 
relative to the average of the fluorescent molecules inside the sample  [33,116].  
Then the Hamiltonian of Anderson's Tight Binding model [28,30,118] is obtained as 
explained in Section 1.2.3 equation (1.13) of the closed system. We can generate the 
eigenfunctions (Ei’s) from the Hamiltonian (H) of the system by diagonalization. Using these 
eigenfunctions (Ei’s) we calculate the average IPR value, <IPR>, of the entire sample images as 
defined in  [22,23,32,46,47]: 
< 𝐼𝑃𝑅(𝐿) >𝐿×𝐿 =
1
𝑁










Where Ei is the i
th eigenfunction of the Hamiltonian H of the optical lattice size L×L, and N is the 
total number of lattice points on the refractive index matrix. 
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It can be shown  [38,83] that the average IPR value <IPR>=<IPR(L)> is directly 
proportional to the structural disorder strength, and can be expressed as:                                                          
⟨⟨𝐼𝑃𝑅(𝐿)⟩⟩ =  ⟨⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿⟩𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 ∼  𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐, (4.2) 
 
 
𝜎(⟨𝐼𝑃𝑅(𝐿)⟩) =  𝜎(⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿)𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 ∼  𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐. (4.3) 
 
 Lastly, the <<IPR(L)>LL>ensemble =<<IPR>> and (<IPR(L)>LL)ensemble =(<IPR>) 
which is directly proportional to the disorder strength (Ld) of the sample and acts as potential 
biomarkers of the of biological cells to quantify any types of abnormalities in glial cells and 
chromatin of the brain cells.  
4.2.2 Brain tissue sample preparation using an alcoholic mouse model 
We study the effects of probiotics on chronic alcoholic brain cortical cells and nuclei 
using a mouse model. In particular, we will study the glial cells: astrocytes and microglia, and 
the DNA/chromatin of the nuclei from cells of the cerebral cortex region of the brain which 
includes the major portion of the CNS. The brain sections were incubated with glial fibrillary 
acidic protein (GFAP) antibody, the microglia cells with anti-TMEM119 transmembrane protein 
antibody, and the chromatin in the nuclei of brain cells with DAPI for confocal imaging  [114].   
The effects of alcohol and probiotics in the brain cells were studied using 8-10 weeks old 
mice (C57BL/6, Harlan, Houston, TX) divided into 4 different groups of 6 mice per group. All 
mice were housed in an institutional animal care facility with 12/12 of the light-dark cycle which 
have easy access to regular laboratory chow and water until the start of the experiment. To be 
more specific, for (1) Control (PF), (2) Ethanol Fed (EF), (3) Probiotic Fed (PF+LP), (4) 
Probiotic and Ethanol Fed (EF+LP), we observed glial cells and nuclei of the brain cells, namely: 
(I) Astrocytes, (II) Microglia, (III) Chromatin.  
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A recent study based on immunofluorescence confocal microscopy showed that alcohol 
elevates the expression of different proteins or dyes as an activation marker in different brain 
cells and components to explain the alcohol effect  [114]. The rationale for choosing the glial 
cells and chromatin to probe the abnormalities in alcohol and probiotic treatment are: (I) 
Astrocytes and anti-GFAP antibody staining: These cells represent a significant portion of the 
CNS and can interact with millions of neurons at a time. They get exposed to external simulators 
such as alcohol and probiotics. For confocal imaging, these cells can be easily tagged by the glial 
fibrillary acidic protein (GFAP) antibody marker. GFAP protein is encoded by the GFAP gene in 
humans. GFAP antibody targets type-III intermediate filaments. Intermediate filaments are 
overactive/expressed in astrocytes in the CNS when the brain is exposed to a chemical such as 
alcohol. Therefore, the molecular-specific type-III intermediate filament can be probed by GFAP 
for confocal imaging to probe the activeness of astrocytes. (II) Microglia and anti-TMEM119 
transmembrane protein antibody staining: Microglia cells are also considered as the 
macrophages of the CNS and include a major portion of the CNS system, which clean up the 
cellular debris and participate in neuroinflammation. These glial also easily get exposed to 
alcohol or drug treatment similar to astrocytes. It is now known that overexpression or 
upregulation of transmembrane protein TMEM119 in microglia due to the presence of 
stimulators like alcohol/probiotic can be tagged by anti-TMEM119 transmembrane protein 
antibody for the molecular specific confocal imaging. (III) Chromatin and DAPI staining: In 
all brain cell nuclei, chromatin is highly abundant. Chromatin is the primary DNA molecular 
component of the cell nucleus. It has been shown that chromatin spatial structures altered with 
the progress of diseases and abnormalities. The chromatin can be easily stained by the standard 
DAPI dye. The nanoscale changes in these types of cells are shown well for the detection of 
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cancer stages. We want to probe the molecular-specific structural alteration of DNA mass 
density in chromatin in nuclei by DAPI staining and confocal imaging tissue sections of the 
cortex region. 
Bio-Marker: The primary marker is to probe the confocal images using the IPR 
technique and to quantify the molecular-specific nanoscale spatial mass density fluctuations as 
the degree of structural disorder, mentioned in Section 4.2.1. 
As described above, mice were randomly divided into 4 categories with 6 mice per group 
and fed with ethanol following a standard protocol in Leiber DiCarli liquid diet (ethanol: 0% for 
2 days, 1% for 2 days, 2% for 3 days, 4% for 1 week, 5% for 1 week, and followed by 6% for 1 
week) with or without L. Plantarum (strain 256, 106 cfu/ml) or isocaloric maltodextrin for 4 
weeks. Control and only probiotic fed animals were pair-fed with isocaloric substitution of 
ethanol with maltodextrin. Animals were pair-fed to maintain a similar diet intake in all groups. 
In the last week of experiments, the average diet intake per mouse per day was 0.7 ml which 
means the L. Plantarum intake by a mouse was about 0.7 ×106 cfu/day and grouped as (1) The 
first group was pair-fed with maltose dextrin in a liquid diet, (2) the second group was fed with 
ethanol liquid diet, (3) the third group was fed with the probiotic in a liquid diet, and (4) the 
fourth group was fed with probiotics in the presence of ethanol liquid diet.  
Brain tissues: When the mice were treated for 4 weeks, they were sacrificed following 
the protocol approved by the University of Tennessee Health Science Center (UTHSC) 
Institutional Animal Care and Use Committee, and their brain sections were removed. The brain 
tissue sections from the cerebral cortex region were then cryo-freeze and sectioned into 10µm 
slices by using a cryostat.                  
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Staining for fluorescence confocal imaging: The different sections of the brain were 
incubated with three different fluorescence agents: anti-GFAP antibody, anti-TMEM119 
antibody, and DAPI according to standard protocols.  
Confocal imaging: Brain cryosections (10μm thick) were fixed in acetone: methanol 
(1:1) at −20°C for 2 min and the sections were rehydrated in PBS (137mM sodium chloride, 
2.7mM potassium chloride, 10mM disodium hydrogen phosphate, and 1.8mM potassium 
dihydrogen phosphate). The tissue sections were permeabilized with 0.2% Triton X-100 in PBS 
for 10 min and blocked in 4% nonfat milk in Triton-Tris buffer (150mM sodium chloride 
containing 10% Tween 20mM and 20mM Tris, pH 7.4). It was then incubated for 1 hour with the 
primary antibodies (mouse monoclonal anti-Alexa Fluor 488-conjugated anti-GFAP and rabbit 
polyclonal anti-TMEM119 antibodies), followed by incubation for 1 hour with secondary 
antibodies Cy3-conjugated anti-rabbit IgG antibodies) and 10 min incubation with DAPI 
(Hoechst 33342 dye). The fluorescence was examined using a Zeiss 710 confocal microscope 
(Carl Zeiss GmbH, Jena, Germany) and images from x–y sections (1μm) were collected by LSM 
5 Pascal software (Carl Zeiss Microscopy). Images were stacked by ImageJ software (Image 
Processing and Analysis in Java; National Institutes of Health, USA) and processed by Adobe 
Photoshop (Adobe Systems, USA). All the images for tissues from the different groups were 
collected and processed under identical conditions.  
IPR analyses: The IPR analyses were performed using a confocal image to quantify the 





Confocal images of the mice's brain cortex tissues stained with different proteins/dyes 
were obtained to study the effect of probiotics in chronic alcoholic glial cells and the chromatin 
of the nuclei. Then the IPR analyses were performed on individual confocal images at 0.8  
0.8µm2 area, as described. The degree of disorder strength or <IPR> at each point at length 
scales, L=0.8µm of cells, and molecular components of the mice brain cells were computed. On 
average, 6 mice per group were considered, and at least 30 confocal micrographs for each 
category: astrocytes, microglia, and the chromatin of mice brain cell nuclei were analyzed 
separately. From these, the std of the ensemble average IPR values were calculated as obtained 
in equations (4.2, 4.3). Finally, the computed (<IPR>) of astrocytes, microglia, and chromatin 
of the mice's brain cells for ethanol-fed (EF), probiotics fed (PF+LP), and probiotics fed with 
ethanol (EF+LP) were compared, relative to the control fed (PF) mice separately.   
The intensity variation in the IPR images represents mass density fluctuations which 
indicate the structural abnormalities present in different glial cells and the chromatin of mice 
brain cell nuclei. In the IPR images, a higher mass density fluctuation is represented by the red 
color, while the lower is represented by the blue color. As can be seen from the IPR images 
(Figs. 4.1,4.3,4.5), the mass density or refractive index fluctuations increase in astrocytes and 
microglia, and the chromatin of the brain cell nuclei when mice were treated with ethanol 
indicates that alcohol altered the brain cells at the submicron scale. However, the slight increase 
in the (<IPR>) value of the glial cells for mice fed with only probiotics might be due to the 
interaction of probiotics with the gut cells/tissues blocking barrier dysfunction and endotoxemia 
to some extent indirectly resulting in structural abnormalities in the brain. On the other hand, 
when the mice were treated with both probiotics and ethanol simultaneously, the (<IPR>) 
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reduced approximately back to normal or less than the normal in both cells and chromatin, which 
suggest that probiotics function well in the presence of alcohol, preventing gut barrier 
dysfunction and endotoxemia and results in an increase in the efficiency of brain functioning. 
Therefore, probiotics such as L. Plantarum are considered good for brain health and help to 
soothe and improve the cognitive function of the chronic alcoholic brain. The results are 
systematically described below. 
4.3.1 Structural alterations in astrocytes 
 Fig.4.1. (a)-(d) show the confocal image of astrocytes incubated with anti-GFAP 
antibodies, while Fig.4.1 (a’)-(d’) are their corresponding IPR images, respectively. In Fig 4.2, 
the bar graphs of relative change in the disorder strength (Ld) or (<IPR>) of brain astrocytes 
cells of ethanol-fed (EF), probiotic fed (LP), and ethanol with probiotic fed (EF+LP) mice with 
control fed (PF) mice are shown. As can be seen from Fig. 4.2, the relative study of (<IPR>) of 
astrocyte brain cells increases when mice were fed with ethanol. In contrast, it significantly 
decreases when mice were fed subsequently with probiotics and ethanol at the same time. It is 
found that probiotics interact with the intestine, which indirectly affects the brain due to the Gut-
Microbiome-Brain axis and may increase the molecular spatial structural disorder of astrocytes 
in the brain cells. Therefore, the (<IPR>) of astrocyte cells of mice fed with probiotics only 
(PF+LP) is relatively higher compared to the PF. Although probiotics were believed to reduce 
intestinal dysbiosis and enhance the gut-brain interaction, the result shows that probiotics may be 
reactive to some specific components of gut cells and hence increase the mass density 




Figure 4.1 Confocal and IPR images of astrocytes. 
Confocal and IPR images of astrocytes (PF, EF, PF+LP, EF+LP): (a)-(d) are the representative 
confocal images of control (PF), ethanol fed (EF), probiotics fed (PF+LP), and ethanol and 
probiotics fed (EF+LP) mice brain astrocytes cells while (a’)-(d’) are their corresponding IPR 
images respectively at length scale L=0.8µm which are distinct. The IPR images show that the 
molecular specific mass density fluctuation in astrocytes increases in the presence of ethanol as 
well as probiotics, but when treated together, they decrease the density fluctuation due to alcohol 
damage. 
cells of EF mice increased by 280% relative to PF. This increase in the Ld or (<IPR>) implies 
that ethanol-induced intestinal dysbiosis, which is a valid approach to dissect the gut-brain 
interaction. This results in an adverse effect in the brain cells, especially in astrocytes, which 
perform a variety of tasks such as axon guidance, maintenance of redox potential, regulation in 
neurotransmitter and ion concentrations, synaptic support, blood flow control, removal of toxins, 
and debris from the cerebrospinal fluid, etc.  [119]. Astrocytes, the most numerous cells within 
the CNS of the brain and can easily be exposed to alcohol. Therefore, chronic alcoholism may 
exacerbate neuronal dysfunction and advances mechanisms in potentiating or nullifying the 
pathway of neuropathologic injury  [120]. However, the (<IPR>) of astrocyte cells decreases 
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by 100% relative to EF when the mice were fed with probiotics and ethanol at the same time. 
This decrease in the (<IPR>) of astrocytes cell of EF+LP supports that probiotics in the 
presence of ethanol are highly efficient and blocked alcohol-induced gut barrier dysfunction and 
endotoxemia, which are indirectly good for brain cells and maintain proper brain functions. 
 
Figure 4.2 Bar graph representation of relative change in the disorder strength in astrocytes. 
Bar graph for the relative values of molecular specific light localization property quantified as 
(<IPR(L=0.8µm)>) or disorder strength (<IPR>~Ld) of astrocytes cells (total n~100 cells: 
aroud~20 cells per micrographs, ~5 micrographs per mouse) of control (PF) mice compared to 
ethanol fed (EF), probiotic fed (PF+LP), and ethanol and probiotics fed (EF+LP) mice. The IPR 
analysis of astrocytes shows that the (<IPR>) or Ld~dn×lc of EF mice increased by 280% 
relative to control. Also, the Ld value of astrocyte cells of PF+LP mice is relatively higher 
compared to the control. This increase in mass density fluctuations indicates some effect of 
probiotics on the astrocytes alone. However, the Ld value of astrocytes cells of EF+LP mice 
decreases by 100% relative to EF mice which implies probiotics get stimulated with ethanol 
decreasing the mass density fluctuations that are beneficial for brain cells. Student’s t-test 




4.3.2 Structural alterations in microglia 
 
Figure 4.3 Confocal and IPR images of microglia 
Confocal and IPR images of microglia (PF, EF, PF+LP, EF+LP): (a)-(d) are the representative 
confocal images of control (PF), ethanol fed (EF), probiotics fed (PF+LP), and ethanol and 
probiotics fed (EF+LP) of mice brain microglia cells while (a’)-(d’) are their respective IPR 
images at sample length L=0.8µm. The IPR images are distinct from the confocal images and 
show that the molecular-specific mass density fluctuations increase in the microglia brain cells in 




Fig. 4.3. (a)-(d), shows the confocal image of microglia incubated with the anti-
TMEM119 transmembrane protein antibody. Fig.3. (a’)-(d’) are their corresponding IPR images, 
respectively. Fig. 4.4, the bar graphs of relative change in the disorder strength (Ld) or (<IPR>) 
of microglial cells of control fed (PF) mice with ethanol-fed (EF), probiotic-fed (LP), and 
ethanol and probiotic-fed (EF+LP) are shown. Fig. 4.3 represents the confocal images and IPR 
images of the microglia cells, where IPR images are highly distinct from confocal images. The 





Figure 4.4  Bar graph representation of relative change in the disorder strength in Microglia. 
Bar graph for the relative study of molecular specific light localization property quantified as 
(<IPR(L=0.8µm)>) or disorder strength (<IPR>~Ld) of microglia cells (total n~100 cells: 
around ~20 cells per micrographs and ~5 micrographs per mouse) of control (PF) mice compared 
to ethanol fed (EF), probiotic fed (PF+LP), and ethanol and probiotics fed (EF+LP) mice. The 
IPR analysis of microglia shows that the (<IPR>) or Ld of EF mice increase by 120% in 
reference to PF mice. The Ld value of microglia cells of PF+LP mice is relatively higher than the 
control. This increase in mass density fluctuations represents some effect of probiotics in brain 
microglial cells. However, the Ld value of microglial cells of mice fed with EF+LP decreases by 
100% relative to EF mice which implies ethanol stimulates probiotics resulting in a decrease in 
the mass density fluctuations that helps in soothing the brain cells. Student’s t-test obtained p-
value for EF is 0.009, PF+LP is 0.03, and EF+LP is 0.01 compared to PF. (P-values <0.05). 
 
microglial cells based on the IPR analysis and shows a relative study induces changes in gut  
microbiota, and as a result of gut-brain interaction it may mitigate of mice for EF, PF+LP, and 
EF+LP with PF. The IPR analysis performed at the same sample length of all cases shows that 
the (<IPR>) of EF mice increases by 120% relative to PF. This increase in the disorder 
strength of microglia brain cells of EF mice suggests that alcohol neuroinflammation, destroying 
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the microglial cells or immune system of the brain. Microglia are considered as the macrophages 
of the CNS that clean up the cellular debris and participate in neuroinflammation to various 
intrinsic and extrinsic stimuli. In addition to well-established phagocytic function and innate 
immune function, microglia are involved in the development of CNS immunopathology  [121]. It 
was founded that alcohol enhances immunomodulatory molecules such as corticosterone and 
endotoxin, which degrade the neuroimmune cells of the brain and selectively modulate the 
intracellular signal transductions of microglia  [122]. Also, the IPR analysis shows that the 
(<IPR>) of microglial cells of mice fed with only probiotics (PF+LP) is relatively higher than 
PF. This higher disorder strength might be due to probiotics interacting with mice gut 
cells/tissues differently which results in microglia cells being more aggressive with the increase 
in mass density fluctuations. Therefore, probiotics used to soothe and strengthen the cognitive 
function of the brain may sometimes be reactive to the neuroimmune system of the brain cells, 
but we have yet to study this in detail. On the other hand, the (<IPR>) of microglial brain cells 
of mice fed with alcohol and probiotics simultaneously decreases by 100% relative to EF. This 
implies alcohol stimulates probiotics and blocked the ethanol-induced gut barrier dysfunction, 
endotoxemia, and liver damage resulting in increasing the efficacy of brain function and hence, 
reducing density fluctuations and in turn, decreasing the disorder strength (Ld) of microglia of 
brain cells. Therefore, this promising result suggests that probiotics with alcohol are good for 
brain cells and enhance the development of CNS immunopathology. 
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4.3.3 Structural alterations in chromatin 
 
Figure 4.5 Confocal and IPR images of chromatin 
Confocal and IPR images of chromatin of brain cells (PF, EF, PF+LP, EF+LP): (a)-(d) are the 
representative confocal images of control (PF), ethanol fed (EF), probiotics fed (PF+LP), and 
ethanol and probiotics fed (EF+LP) while (a’)-(d’) are their respective IPR images of chromatin 
of mice brain cells at the sample length L=0.8µm. The IPR images are distinct from the confocal 
images and show that the molecular specific mass density fluctuation increases in the chromatin 
of mice brain cell nuclei in the presence of ethanol which decreases when they were fed with 
alcohol and probiotics simultaneously.  
Fig.4.5. (a)-(d) show the confocal images of brain cell nuclei incubated with DAPI, while 
Fig. 4.5. (a’)-(d’) are their corresponding IPR images, respectively. In Fig. 4.6, the bar graphs 
relative change in the disorder strength (Ld) or (<IPR>) of nuclei in the brain cell of control 
(PF) mice with ethanol fed (EF), probiotic-fed (LP), and ethanol and probiotic-fed (EF+LP) are 
shown. The molecular-specific IPR analysis of DAPI stained confocal images of mice brain cell 
nuclei at sample length, L=0.8µm indicates that the mass density fluctuations or (<IPR>) of EF 
mice increases by 25% relative to PF. This is because of chronic alcohol-induced intestinal 
mucosal barrier dysfunction in the gut, which as a result induces an adverse effect in the brain 
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due to gut-brain interaction. This adverse effect is in some way related to an increase in 
submicron scale mass density fluctuation or the (<IPR>) in the chromatin of EF mice brain 
cells. Hence, the rise in DNA mass density fluctuations of the chromatin due to alcohol is 
responsible for an increase in the degree of disorder strength (Ld). Persistent alterations to the 
chromatin structure are factors for epigenetics inheritance and can have a long-lasting influence 
on the activity and connectivity functions of the brain  [123]. The (<IPR>) of chromatin in the 
brain cell nuclei of mice fed with only probiotics (PF+LP) is relatively lower compared to the 
PF, indicating that probiotics are good for the mice digestive system that is correlated with 
soothing and well-functioning of the brain especially in chromatin of nuclei. Further, the 
(<IPR>) value of chromatin in brain nuclei of mice fed with alcohol and probiotics at the same 
time decreases by 40% relative to PF. This decrease in the (<IPR>) of the chromatin of mice 
cell nuclei fed with alcohol and probiotics at the same time is because probiotics in the presence 
of ethanol get highly stimulated and attenuate alcohol-induced intestinal mucosal barrier 
dysfunction, which is good for the chromatin of the brain cell nuclei and allow the brain to 
soothe and function better. 
The molecular-specific structural quantification of probiotic's effect on alcoholic brain 
cells using the confocal image and IPR analyses shows that alcohol affects the digestive system, 
which indirectly damages the glial cells and the chromatin of the nuclei of the brain cells. We 
speculate that the gut-brain interaction associated with these findings involves endotoxin 
absorption due to intestinal barrier dysfunction and gut dysbiosis. The probiotic, L. Plantarum by 
itself caused a small increase in the degree in the disorder strength or (<IPR>) of astrocytes 
and microglia cells while a decrease in the chromatin of the brain cells. However, the obtained 
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result strongly supports that the probiotics L. Plantarum feeding very effectively blocked 
alcohol-induced changes in astrocytes and microglia.  
 
Figure 4.6 Bar graph representation of relative change in the disorder strength of chromatin.  
Bar graph for the relative study of molecular specific light localization property quantified as 
(<IPR(L=0.8µm)>) or disorder strength (<IPR>~Ld) of chromatin in nuclei (total cells n~400, 
around ~80 cells per micrographs and ~5 micrographs per mouse) of control (PF) mice 
concerning to ethanol fed (EF), probiotic fed (PF+LP), and ethanol and probiotics fed (EF+LP) 
mice. The IPR analysis of chromatin of the mice brain cells shows that the (<IPR>) or Ld of EF 
mice increases by 25% relative to control. The Ld value of chromatin in nuclei of mice fed with 
PF+LP is relatively lower compared to the control. This decrease in mass density fluctuations 
represents some effect of probiotics in chromatin of the brain cell nuclei. However, the Ld value 
of chromatin of mice brain cell nuclei fed with EF+LP decreases by 40% relative to PF mice due 
to the decrease in mass density fluctuations which implies probiotics in the presence of ethanol is 
more active and help in soothing the brain function. Student’s t-test obtained p-value for EF is 
0.01, PF+LP is 0.002, and EF+LP is 0.007 compared to PF. (P-values <0.05). 
 
4.4 Conclusions 
The molecular-specific light localization technique, IPR, is used to study the effect of 
probiotics in chronic alcoholism in glial cells, astrocytes, and microglia, and the chromatin of 
brain cell nuclei using a confocal image and a mouse model. Changes in the molecular specific 
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structural disorder were probed for: (i) upregulation of type III intermediate protein spatial mass 
density in astrocytes, (ii) upregulation of transmembrane protein anti-TMEM119 spatial mass 
density in microglia, and (iii) rearrangements of DNA mass density in nuclei of neural cells. The 
submicron scale mass density fluctuations quantified as the std of average IPR or (<IPR>)~Ld 
using a confocal image show an increase in disorder strength (Ld) of the molecular specific 
probing of astrocytes and microglia cells, as well as the chromatin of brain cell nuclei of alcohol-
treated mice. This increase in the disorder strength or mass density fluctuations in brain glial 
cells and chromatin is due to gut-brain interaction confirms alcohol-induced gut barrier 
dysfunction, endotoxemia, and liver damage and eventually leads to neuroinflammation, 
especially in glial cells and the chromatin of brain cell nuclei due to gut-brain interaction. On the 
other hand, probiotics fed control mice have a small increment in the disorder strength of brain 
glial cells, which may be due to the interaction of probiotics, L. Plantarum in gut cells/tissues 
differently increasing mass density fluctuations. Therefore, the Ld value increases in the 
astrocytes and microglia cells when fed with only probiotics invite a detailed study to elucidate 
plausible reasons for an adverse effect of L. Plantarum in glial cells, although probiotics are 
considered reasonable and used to improve the cognitive function of the brain. Interestingly, a 
decrease in the Ld value in glial cells and the chromatin of brain cell nuclei fed with ethanol and 
probiotics simultaneously relative to control and ethanol fed mice indicate that L. Plantarum in 
the presence of alcohol gets highly stimulated and increase the efficacy and well-functioning of 
the brain. That means, these probiotics first increase the efficacy of the digestive system and as a 
result of gut-brain interaction, which indirectly helps in soothing the brain's physical structure 
and enhances the multifunctionality of the brain. Therefore, this almost reversible effect of 
probiotics when it is given with the alcohol on the brain cells/components could be one of the 
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ways to mitigate neurological abnormalities in the brain cells due to alcohol or any other drug. 
As an illustration of the potential application of the recently developed mesoscopic physics-
based molecular-specific IPR technique via confocal imaging, we have successfully quantified 
probiotic effects on glial cells and chromatin of the brain cell nuclei based on the structural 




QUANTIFICATION OF NANOSCALE STRUCTURAL ALTERATIONS IN OVARIAN 
CANCER CELLS TO STUDY ANTI-CANCEROUS DRUG EFFECT USING TEM-IPR 
This chapter is adapted from the author’s published article with copyright permission 
from the publisher. Ref [57] P. Adhikari et. al., "Studying nanoscale structural alterations in 
cancer cells to evaluate ovarian cancer drug treatment, using transmission electron microscopy 
imaging," Physical Biology 17(3), 036005 (2020).  
Although, the main probing technique in this dissertation is optics/photonics that are 
within the diffraction limit (resolution ~200nm). However, it would be interesting to see the 
properties of the cell at nanoscale resolution, that can support the optical techniques. In this 
chapter, we have used TEM imaging to probe the structural disorder below 100nm and studies 
the effects of anti-cancerous drugs on ovarian cancer cells. 
Anti-cancerous therapies are intended for the growth inhibition of cancer cells which are 
initially at the nanoscale level; however, it is challenging to detect the efficacy of such drugs in 
the early stages of treatment. A unique method to assess the impact of anti-cancerous drugs on 
cancerous cells/tissues is to probe the nanoscale structural alterations. For this, TEM imaging on 
thin cell sections is performed to obtain their nanoscale structures where we can probe up to 1nm 
structure. In this work, we apply the IPR technique in TEM imaging (TEM-IPR) to study the 
effect of different anti-cancerous drugs on ovarian tumorigenic cells, using their nanoscale 
structural alterations as a biomarker. Based on the degree of disorder strength the efficacy of the 
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anti-cancerous drug and level of tumorigenicity are quantified. Hence the potential applications 
of the technique for cancer treatment and diagnosis are discussed. 
5.1 Introduction 
5.1.1 Why TEM imaging and probing nanoscale changes in cancer? 
TEM imaging is a method where we can probe ~1nm resolution within the sample, and 
this has been used for imaging of cells at the nanoscale to see the inner structures of the cells, in 
general, qualitatively. It has been established that cancer progression is associated with the 
nanoscale structural alteration in a cell due to rearrangements of the building blocks of the cell 
such as DNA, RNA, and lipids. Therefore, TEM imaging with spatial nano-resolution is a good 
modality to look at the nanoscale cell structures and measure cancerous changes in cells at the 
nanoscales. 
The structural alterations in cells have been characterized by visible-light microscopy 
techniques within the diffraction limit. For example, the newly developed spectroscopic 
microscopy technique has shown success in probing these alterations to some degree that are 
prominent in early carcinogenesis [16,17,58,124–126], and these nano morphologies are 
associated with the basic cellular building blocks. Therefore, TEM imaging is a good modality to 
probe cancerous changes in cells at the nanoscale level, very much beyond the diffraction limit 
of light. The details of the TEM schematics and application in scientific research are explained in 
Chapter I Section 1.2.1. Furthermore, the recently developed light wave localization technique, 
IPR using TEM imaging, has shown success in quantifying the degree of structural changes in 
one parameter, known as the degree of the structural disorder [22,23]. In particular, using the 
IPR method, a TEM image is used to construct a disordered 2D mass matrix, and from this, we 
generate a 2D refractive index matrix. Optical waves are then solved for their eigenvalues and 
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eigenfunctions using the refractive index matrix with closed boundary conditions. The light 
localization properties are measured by the average inverse participation ratio, <IPR>, and 
standard deviation of the IPR, σ(<IPR(L)>)cells, of the eigenfunctions of the light waves in these 
samples. It is shown that the degree of structural disorder is proportional to the <IPR> or 
σ(<IPR(L)>)cells  [32,33]. Therefore, the <IPR> can be used as a measure of the degree of 
nanoscale structural disorder, and to monitor structural change in cells under diseases condition. 
The IPR method is a very versatile approach. The IPR method, using TEM imaging, has been 
recently generalized to study the structural changes in brain and colon cells in chronic 
alcoholism  [127,128]. Furthermore, the IPR method also extended to study the molecular 
specific (DNA, histone, etc.) structural changes in cells by using molecular-specific fluorophores 
and confocal microscopy imaging  [38,83]. 
5.1.2 Ovarian cancer study 
Ovarian cancer (OC) ranks 5th in cancer-related deaths among women and accounts for 
more deaths than any other cancer of the female reproductive system. The American Cancer 
Society (ACS) estimated new cases of OC in the USA in 2019 would be 22,530, whereas 
estimated deaths would be 14,000. Most OC cases are diagnosed at a very late stage, of which 
51% are diagnosed as stage III and 29% are diagnosed as stage IV  [129]. The exact cause that 
triggers OC is not clearly understood but there are several risk factors such as fertility therapy, 
late pregnancy, family history, hormone therapy after menopause, etc. are associated with the 
development of OC. Metabolic alterations, suppression of tumor suppressor genes, and 
oncogenic activations are also considered as triggering factors for OC initiation and progression 
of the disease  [130,131]. Although initially sensitive to chemotherapy treatment, however, the 
majority of OC patients develop chemoresistance. 10 years survival rate for most patients of all 
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stages of OC is ~30%. Development of chemoresistance, widespread disease during the time of 
diagnosis, and tumor recurrence are the major challenges in the therapeutics of ovarian 
cancer  [132]. 
In this study, we are focusing on analyzing the impact of novel anti-cancerous drug 
treatment in the tumor forming OC cell line in vitro. HSulf-1 knockdown OV202 cells are 
selected for this study for their aggressive tumor forming ability and high proliferation 
rate [133,134]. This method of analysis is aimed to understand the effect of anti-cancerous drugs 
on cells in the early phases of treatment. Here we propose a novel TEM-IPR approach to assess 
the impact of anti-cancerous drugs in cancerous cells by quantifying the degree of nanoscale 
structural disorder. 
5.2 Methods 
5.2.1 IPR technique using TEM images 
TEM experiment has a resolution of ~1nm and can identify the nanoscale architectural 
alterations inside the cells which take place in normal cells when affected by cancer. These 
nanoscale alterations happen in the cells due to the rearrangement of the basic building blocks of 
the cells, such as DNA, RNA, lipids, macromolecules, etc. This results in mass density 
fluctuations in the cells. Using a thin slice of a cell (~100nm), the mass density variations can be 
probed by TEM imaging. The detail of the TEM schematic and imaging is presented in Chapter I 
Section 1.2.1. The IPR calculation is an efficient technique to measure and quantify the 
cancerous level of aggressiveness in a cell through its mass density fluctuations. A higher 
<<IPR(L)>> or σ(<IPR(L)>) value indicates an increasing amount of the nanoscale mass 
density fluctuations in cells. The IPR technique is described in detail in Chapter I Section 
1.2.3  [22,23,32,33]. However, we will describe the IPR technique using TEM images in brief.    
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The refractive index of a thin cell slice at a point n(x,y) can be written as n(x,y) = 
no+dn(x,y), where no is the average refractive index and dn(x,y) is the fluctuation of refractive 
index at (x,y) indicated voxel. In the thin sample, a voxel of area dxdy at position (x,y) and 
thickness dz, the transmission TEM intensity: ITEM(x,y)=I0-I0αd(z), where α is a transmission 
related constant depends on the mass of the voxel as shown in Chapter I Section 1.2.3. TEM 
image intensity at any voxel point (x,y) for a thin cell sample can be expressed as ITEM(x,y) = 
I0TEM + dITEM(x,y), where I0TEM is the average pixel intensity and dITEM(x,y) is the fluctuation part 
of the pixel intensity. Here, the intensity fluctuation ITEM(x,y) <  I0TEM (average intensity), where 
I0TEM=<I(x,y)>(x,y) and dITEM(x,y)=ITEM(x,y) - <I(x,y)>(x,y) and dn(x,y) < n0.  
Therefore, the intensity of a TEM image is linearly proportional to the mass, M, and 
refractive index, n of the voxel as shown in Chapter I equation (1.10, 1.11), except ITEM is the 
intensity of the TEM image. From this, we can calculate the optical potential of the voxel point 
as εi(x,y) obtained in Chapter I equation (1.12) to generate an optical lattice. 
Knowing the optical potential at every point, the Anderson disordered tight-binding model TBM 
Hamiltonian [28,30,118] can be obtained as in Chapter I equation (1.13) for the TEM closed 
system. For a sample size of length L in the TEM image, we have L×L sample area in the TEM 
image. We calculate the average IPR at length L where L=NL×dx (dx=dy). As there are 
N=NL×NL numbers of lattice points, thus, there will be N eigenvalues, as well as the same 
number of eigenvectors. Finally, the average IPR value of the sample of length L or size L×L is 
defined as  [22,23,32,33,46,47]: 
  < 𝐼𝑃𝑅 >𝑁 =
1
𝑁
∑ ∫ ∫ 𝐸𝑖











where Ei denotes the i-th eigenfunction of the Hamiltonian, N is the total number of potential 
points on the refractive index matrix (i.e., N=(L/dx)2). It has been shown that the ensemble-
averaged IPR value (i.e., ensemble-averaged of similar type of cells): <<IPR(L)>> = 
<<IPR(L)>L×L> or (<IPR(L)>, is proportional to the degree of structural disorder Ld. Then,  
⟨𝐼𝑃𝑅⟩ ≡< 𝐼𝑃𝑅 >𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒  ~ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐 ,  (5.2) 
(< 𝐼𝑃𝑅 >) ≡ (< 𝐼𝑃𝑅 >)𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 ~ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐 . 
 (5.3) 
Equation (5.1) presents the average value of one IPR pixel at length (L) that is 
constructed from the L×L TEM area or N pixels of the TEM image. Our statistical analysis 
involves calculating the average and standard deviation of the disorder strength of IPR values, 
i.e. Ld values over the cell samples for the length of a given sample. Using this structural disorder 
strength <<IPR(L)>> or (<IPR(L)>) or Ld as a biomarker, we study the structural properties of 
ovarian cancer cells with anti-cancerous drug treatments. 
5.2.2 Sample preparation and TEM imaging 
5.2.2.1 Ovarian normal and cancer cell lines 
 OV202 cell line is a low-passage primary ovarian cancer cell line established at the Mayo 
Clinic  [133]. OV202 NTC (expressing HSulf-1) and Sh1 cells (HSulf-1 deficient) are developed 
by Dr. Shridhar’s group at Mayo Clinic and are described earlier elsewhere  [134]. Subcutaneous 
injection of OV202 Sh1 cells resulted in tumor formation in nude mice, whereas HSulf-1 
expressing OV202 NTC cells did not form tumors  [133]. Both cells were grown in minimum 
essential medium alpha 1X (Cellgro) supplemented with 20% fetal bovine serum (Biowest) and 
1% penicillin-streptomycin (Cellgro). All cells were grown in the presence of 1 μg/ml puromycin 
as a selection marker for the HSulf-1 shRNA cells were treated with 10 µl of AACOCF3 or 
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MAFP (cPLA2 inhibitors; Cayman chemicals) for 24 hours. Following this treatment, cells were 
washed twice with PBS and then fixed in Trump’s fixative containing 4% formaldehyde and 1% 
glutaraldehyde in phosphate buffer pH ~7.3, post-fixed in 1.0% OsO4, dehydrated with ethanol 
gradation, and transitioned into propylene oxide for infiltration and embedding into super epoxy 
resin.  
5.2.2.2 TEM imaging 
Cell samples were fixed in Trump’s fixative (pH 7.2) at 4°C overnight, spun down and 
the supernatant removed. They were re-suspended in agarose which was cooled and solidified. 
The cells in agarose were then post-fixed in 1% OsO4, dehydrated through a graded series of 
ethanol, and embedded in Spurr resin. 100nm (or 0.1μm) ultra-thin sections were mounted on 
200-mesh copper grids, post-stained with lead citrate, and observed under a JEOL JEM-1400 
transmission electron microscope at 80kV. 
5.3 Results and discussions 
The TEM images of the ovarian cancer cells are obtained as described in the above 
section. IPR analyses were performed for the samples on different length scales of TEM images. 
The IPR averaging of a sample length L, <<IPR(L)>> over a single cell, then over the different 
cells, was performed for obtaining the ensemble averaging: <<IPR(L)>>=<<IPR(L)>L×L>. As 
discussed above, the <<IPR(L)>> value for each TEM image was calculated and provides the 
degree of the structural disorder strength at a defined length scale L. 
Fig. 5.1(a)-(d) are the representative grayscale TEM images of a thin section (~100nm) of 
a cell from the following ovarian control/cancer cell lines: (i) non-tumorous NTC, (ii) tumorous 
Sh1, (iii) Sh1 treated with drug AACOCF3 (Sh1-AACOCF3), and (iv) Sh1 treated with drug 
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MAPF (Sh1-MAFP). For each case (i.e. for a particular cell line) study, 8 different cells were 
taken from the cell line for averaging. Figure 5.1(a’)-(d’) are the corresponding (<IPR(L)>) 
images of  Fig. 5.1(a)-(d), at a length scale of 165nm and sample size of 165165nm2. It is 
reported that structural alteration in carcinogenesis happens around sample length  L~100nm or 
sample size LL  [127], which is around the basic building blocks of the cell. Therefore, we have 
taken a length scale of 165nm which is higher than 100nm. For a better understanding of the IPR 
images at different length scales, we have also added IPR images at two different length scales 
(one 82nm <100nm and another 206nm>100 and 165nm), in the Supplementary Documents. As 
can be seen from Figure 5.1, σ(<IPR(L)>) images represent different intensities of disorder 
patterns in the cell line which are distinct from conventional grayscale TEM images. In the IPR 
images, intensities patterns of higher fluctuations in the cells are represented by the red spots and 
lower intensities with blue. In the figure, it can be seen that the increasing fluctuation or 
(<IPR(L)>) value increases from the less proliferating NTC cells to highly proliferating Sh1 
cells and decreasing of the fluctuations or (<IPR(L)>) values decrease with the treatment of 
two different anti-cancerous drugs, AACOCF3 and MAFP. The drug effect can be distinctly 






Figure 5.1 TEM and IPR images of anti-cancerous drugs treated ovarian cancer cells. 
(a)-(d) are the TEM images and (a’)-(d’) are their respective IPR images at the sample length 
(LL=165165nm2) from ovarian cells of the following:  non-tumorous (OV202 NTC); tumorous (OV202 
Sh1);  AACOCF3 treated tumorous Sh1, Sh1-AACOCF3; and MAFP treated tumorous Sh1 Sh1-MAFP. 
IPR images are distinct from the TEM images. 
 
TEM images and their corresponding IPR images for representative ovarian cancer cases 
(NTC, Sh1, Sh1-AACOCF3, and Sh1-MAFP) at two different sample lengths: one 82nm 
<100nm or 165nm and another 206nm>100nm or 165nm, are presented for the better 
clarification. It has been reported that structural changes are significant around 100nm and in this 
particular experiment as seen from Fig. 5.2 prominent changes start around 150nm. Therefore, 
we have taken sample length 165nm to study the anti-cancerous drug effect in ovarian cancer 
cells. Here, from the presented IPR image at different length scales it can be seen that IPR 






Figure 5.2 TEM and IPR images of ovarian cancer cells at different length scales.  
(a)-(d) are the TEM images, while (a’)-(d’), and (a’’)-(b’’) are their respective IPR images at the 




] below and above the presented IPR 
image at sample length, L = 165nm respectively from ovarian cells of the following: non-
tumorous (OV202 NTC); tumorous (OV202 Sh1);  AACOCF3 treated tumorous Sh1, Sh-




Fig. 5.3 shows the length (L) dependent fluctuations with the sample size (L×L). We 
plotted, variations of the standard deviation  (<IPR(L)>) vs L with the increase of sample 
lengths: L = 41, 82, 123, 165, 206, 247, 288 nm. As the deviation started appearing in the mean 




systematically well below and above 100nm. These lengths are for the cells from the following 
cell lines: non-tumorigenic (OV202 NTC); tumorigenic (OV202 Sh1); AACOCF3 treated 
tumorigenic Sh1 (Sh1-AACOCF3); and MAFP treated tumorous Sh1 (Sh1-MAFP). As can be 
seen from the figure that the deviation in the degree of nano-fluctuations between non-
tumorigenic cells NCT and tumorigenic cells Sh1 started becoming prominent around the length 
scale ~100nm. Interestingly, the degree of nano-fluctuations of anti-cancerous drugs treated Sh1 
tumorigenic cells reverse to that of the non-tumorigenic NTC cells. This confirms the efficacy of 
these two anti-cancerous drugs. 
  
Figure 5.3 Sample length scale (L) dependence of σ(<IPR(L)>). 
Variations of the standard deviation σ(<IPR(L)>) with the increase of sample length L, for cell 
lines non-tumorigenic (OV202 NTC); tumorigenic (OV202 Sh1); AACOCF3 treated tumorigenic 
Sh1 (Sh1-AACOCF3); and MAFP treated tumorous Sh1 (Sh1-MAFP). It can be seen that the 
deviation between NTC and Sh1 started to become prominent around the sample length/length 
scale ~100nm. Interestingly, the drug-treated Sh1 tumorigenic cells' fluctuation degrees reverse to 






Figure 5.4 Bar graph representation of anti-cancerous drug-treated ovarian cancer cells 
Bar graph representation of the standard deviation of the degree of structural disorder strength Ld 
~σ(<IPR(L)>) calculated from the TEM images for: non-tumorous (NTC), tumorous (Sh1), 
AACOCF3 treated tumorous cells Sh1-AACOCF3, and MAFP treated tumorous cells Sh1-
MAFP. For the normal cells, IPR analysis was performed at the sample size 165×165nm
2
. The 
result shows Ld value increases from non-tumorous to tumorous cells, then it decreases when 
these tumorous cells are further treated with anti-cancerous drugs AACOCF3 and MAFP, 
interestingly the Ld value returns almost back to the same value of the non-tumorous cells (p-
values < .05). This may imply that anti-cancerous drugs are working well in ovarian cancer 
treatment. 
  
Figure 5.4 presents the bar graphs of the standard deviation of calculated (<IPR>) or 
(Ld) value, of the ovarian cells at the fixed-length scale of 165nm. The variations are similar at 
lower sample length scales >165nm, however, we have chosen 165nm to show a prominent 
difference. Statistically, the standard deviation is the more reliable marker than the average, as it 
only depends on the width of the distribution, irrespective of the mean position. The result shows 
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the standard deviation of the degree of structural disorder (<IPR>) value increased by 70% 
from NTC to Sh1 cells. Furthermore, when Sh1 cells were treated with 2 different anti-cancerous 
drugs, AACOCF3 and MAFP, the (<IPR>) values decreased by around 58% for AACOCF3 
and 54% for MAFP, relative to the (<IPR>) value of the Sh1 tumorous cells. In particular, with 
the treatment of the anti-cancerous drug, the structural biomarker parameter (<IPR>) or Ld 
value decreased nearly back to the normal value. The normalcy detection of these anti-cancerous 
drug-treated cancerous cells may require further investigations using different modalities. It has 
been earlier shown that AACOCF3 is a better anti-cancerous agent producing more anti-
cancerous effects in OC cells compared to MAFP [135]. It can be seen in Fig. 5.4 that similar 
trend of bar graphs which show a reduction in the degree of structural disorder (<IPR>) value 
for AACOCF3 (58%) > MAFP (54%), consistent with the known qualities of the drugs, in this 
length scale. Hence, the quantitative analysis technique, called IPR, quantifies the nanoscale 
structural disorder (<IPR>) or Ld, as an important biomarker to study the structural alterations 
at the nanoscale level and has the potential to detect the effect of anti-cancerous drugs in 
carcinogenesis ovarian cancer.   
5.4  Conclusions 
The nanoscale mass-density fluctuations are quantified with the progression of ovarian 
carcinogenesis, as well as the effects of two anti-cancerous drugs on non-tumor forming 
OV202NTC and tumor forming OV202Sh1 cells are studied using the TEM imaging and IPR 
technique. TEM experiment has a resolution of ~1nm and can identify the nanoscale 
architectural alterations inside the cells which take place in normal cells due to the rearrangement 
of the very basic building blocks of the cells, such as DNA, RNA, lipids, macromolecules, etc. 
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This results in nanoscale mass density fluctuations in the cells which can be probe using TEM 
imaging. The nanoscale fluctuations are quantified by the STD value of the <IPR(L)>L×L, 
(<IPR(L)>)cell, performed over similar types of cells or ensembles of the samples. Results show 
an increase in the nanoscale fluctuations or  (<IPR(L)>) value from non-tumorous NTC to 
tumorous Sh1 cells. The (<IPR(L)>) values for two different drugs treated tumorous cells, Sh1-
AACOCF3 and Sh1-MAFP, have reduced value from tumorous cells Sh1 and the reduced values 
are nearly the same to the NTC non-tumorous cells. Earlier IPR analysis of a different cell line 
has verified the increase of nanoscale structural disorder with the progression of cancer  [22,23]. 
Based on the results presented, we investigate the potential applications of the IPR technique in 
measuring and quantifying the effectiveness of different anti-cancerous drugs on ovarian cancer 
treatment. This quantification of the effectiveness of anti-cancerous drugs in ovarian cancer 
treatment could enhance better drug treatment modalities at their earliest and helps to control the 
deadly ovarian cancer. Although this study is based on ovarian cancer cells, however, the 
technique can be applied to the varieties of cancers to assess the effectiveness of different anti-
cancerous drugs in treatment. 
Our technique is based on the linear transmission of the TEM intensity through thin cell 
samples as described in the Method. The TEM intensity transmits well till ~500nm of thin cell 
samples, the technique works until that thickness of the samples. Because of the thin sample, this 
method can be applied to heterogeneous cell samples. 
A cell is around 5 microns thick, and the TEM sample thickness is around 100nm, 
therefore, 50 TEM slices per cell can be generated. Thus, it is important to consider ensemble 
averaging correctly by choosing similar types of TEM micrographs. For each cell, TEM 
micrographs are chosen around the middle of the cell by observing the maximum size of the 
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nucleus. The maximum changes in a cancerous cell can be captured by considering the largest 
portion of the cell or nucleus. Not considering proper ensemble averaging, results may vary. 
At present, the super-resolution optical microscopy techniques have achieved an order of 5-10nm 
resolutions targeting particular types of molecules in a cell  [136–138]. However, in the case of 
TEM imaging, we can target whole cells or nuclei with ~1nm resolution. This nanoscale 
resolution brings advantages of the TEM imaging for the quantification of structural disorder and 
its alterations at submicron to nanoscales in the nucleus/cell, in progressive carcinogenesis, or 
any other cell abnormalities. It would be interesting to compare the results of TEM-IPR analysis 
with the super-resolution microscopy in progressive carcinogenesis or abnormalities of a cell, in 









CONCLUSIONS AND FUTURE WORK 
The elastic light scattering signal from cells/tissues can be recorded after propagating 
through the cells/tissues which carries tremendous information useful for cancer diagnosis and to 
study drug effects in cancer treatment or any other abnormalities. The 1D backscattered signals 
are sensitive to refractive index fluctuations at any length scale including way below the 
wavelength range. Furthermore, we have studied molecular-specific light localization techniques 
using TEM and confocal imaging, a powerful method to quantify molecular-specific changes in 
the mass density of refractive index fluctuation in cells/tissues. In this dissertation, using both 
PWS (open scattering) and IPR (close scattering) techniques, we probe the structural alteration of 
the cells/tissues and quantify the degree of structural disorder to study cancer stages, drug effects 
in cancer treatment, and chronic alcoholic brain abnormalities.  
With the addition of finer focusing using a highly sensitive 3D motorized scanning stage 
in the developed PWS technique (resolution ~40nm), we have shown that these backscattered 
signals from cells/tissues are sensitive to refractive index fluctuations below the wavelength 
within the diffraction limit and can distinguish the stages of progressive cancer in TMA. The 
result also demonstrates that the use of low NA illumination prevents interference between the 
1D adjacent channels, increasing the sensitivity of the technique to nanoscale refractive index 
fluctuations. Likewise, the PWS quantification of 3D structure tumor developed from cancer 
cells 2D structure reflects the unique ability of PWS to study the anti-cancerous drug effect in 
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cancer treatment. On the other hand, we quantify refractive index or mass density fluctuations in 
a closed weakly disordered heterogeneous optical system based on light localization technique 
using confocal and TEM imaging. In the case of carcinogenesis or any other abnormalities, DNA 
molecules inside the cells undergo structural alteration due to the mass density variation and 
rearrangements which result in the light wave eigenfunction localization. This results in nano to 
microscale structural alteration which can be detected based on a molecular specific light 
localization technique using a confocal image as demonstrated by quantifying probiotic effect in 
alcoholic brain cells. Our results also show that the TEM micrograph can be effectively used to 
quantify the molecular specific mass density fluctuations in terms of the degree of disorder 
strength using the IPR technique to detect carcinogenesis and drug effect in cancer treatment. 
In this chapter, a summary of the developed spectroscopic systems, in a bid to elucidate 
the promising applications of these techniques are reported. In addition to this near-future studies 
and recommendations using these techniques are presented.  
6.1  PWS study conclusions 
The developed finer focusing mesoscopic physics-based imaging technique, PWS can 
scatter precise scattering volume to detect minute structural changes in terms of the refractive 
index fluctuations below the sub-diffraction length scale, within the diffraction limit. In this 
dissertation, the finer focusing PWS technique was successfully used to quantify the degree of 
disorder strength (Ld) and distinguished the stages of cancer in commercially available paraffin-
embedded deadly cancer TMAs. This result could help to standardized cancer diagnostic 
modalities and use these samples to study the drug effect in cancer treatment. With the validation 
of added finer focusing, our results demonstrate that PWS was able to differentiate different 
stages of cancer, especially for paraffin-embedded pancreatic, breast, colon, and prostate cancer 
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tissues. The PWS result shows that for each TMA cancer tissue, the degree of disorder strength 
increases significantly with an increase in cancer stages for each cancer type supporting the fact 
that mass density fluctuations or refractive index fluctuations increase in progressive cancer. 
Lastly, the flexibility provided by the highly sensitive PWS technique and commercially 
available TMA samples to distinguish the cancer stages opens a broad path to explore for 
generalizing the structural changes in progressive cancer and drug effect for effective cancer 
treatment/diagnosis. 
In addition to this, the structural properties of tumors developed by the xenografting of 
drug-sensitive and drug-resistive prostate cancer (PC) cell lines were quantified using the finer 
focusing PWS technique. The results indicate that tumor tissues (3D model) grown by 
xenografting PC cells (2D model) resistant toward docetaxel have a higher degree of disorder 
strength (Ld) than drug-sensitive PC cells. Cancerous cells that survived through drug exposure 
are more aggressive and develop different morphological structures resulting in higher mass 
density fluctuation due to the rearrangement of macromolecules, large pore sizes, changes in 
cytoskeleton nanoarchitecture. This result further concludes that xenografted tumors from the 
drug-sensitive and drug-resistant PC cell lines maintain the same type of structural properties 
when grown to 3D structures supporting a strong correlation in structural properties of cells 
grown on 2D glass slide structure surfaces. Therefore, the PWS study of xenografted tumor 3D 
structures that replicate the structural properties of cancer cells could be a reliable, easy, and 
quantitative approach to diagnose chemo-resistance for the future. This promising result seeks an 
application to monitor the effect of chemotherapy drugs on a different level of tumorigenicity by 
both in-vitro and in-vivo analysis.   
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6.2 Future work in PWS and its applications 
The PWS microscopic setup developed in this work is highly sensitive, fast, and cost-
effective. The results obtained from the engineered PWS technique may have profound 
biological and medical implications. In the fields of cancer biology and medicine, the PWS 
technique could help us to understand the structural properties of cancerous cells/tissues as well 
as chemotherapy or anti-cancerous drug effects in cancerous cells/tissues at the nanoscale level 
which need to be explored in detail. Monitoring the growth of cancerous cells/tissues with or 
without anti-cancerous drugs using the PWS technique and xenograft model for different types 
of cancer could play a crucial role in cancer control in the coming days. The quantification of 
structural changes in cells/tissues due to abnormalities such as radiation exposure, alcohol, stress, 
etc. might also be interesting to study next with PWS. At this point, it may not be possible to 
identify which specific structure is responsible for an increase in the degree of disorder strength 
(Ld) and associated with molecular mechanism, however, we can have some insight into how 
these nanoscale structural changes are associated with cancer progression and anti-cancerous 
drug treatments. And the improvement in the construction of the disorder map or Ld map with the 
reduced noise performance in the short interval of time could provide an opportunity to visualize 
which part is specifically affected by the diseases. Further, the flexibility provided by the 
spectroscopic technique using commercially available TMA samples to standardize the early 
cancer diagnostic and study the drug effect in cancerous treatment opens exploration for 
generalizing the structural change in progressive cancer for effective cancer treatment. With 
these promising applications of PWS in biomedical implications, we want to move forward with 
the PWS technique from clinical research to clinical trials especially to study drug-sensitive and 
drug-resistive different cancer treatment cases.  
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In addition to this, we can work on the PWS instrumentation to increase the sensitivity of 
the system and make it more compatible with the in-hospital application. For this, we can use a 
highly sensitive and compatible liquid crystal tunable filter with less than 1nm resolution and 
replace the existing CCD camera with a low cooling effect and high quantum efficiency (QE) 
CCD camera. Also, we can replace the existing 3D motorized scanning stage with a highly 
sensitive stage for precise focusing within the working distance of the low NA objective. To 
make this technique compatible with both in-vitro and in-vivo diagnostic we can replace the light 
source and combination of lenses as mentioned in Chapter I Section 1.1.1 with optical fibers and 
develop the system in a portable microscopic setup, that can be used in-vivo. We are planning to 
modify the existing BX61 bright field microscope replacing the existing light source with an 
optical fiber-based halogen lamp (100W) light source and mounting an LCTF filter coupled with 
a Retiga 3 CCD camera on the top of a microscope to capture the spectroscopic images. That 
means, we want to validate the possibility of using a spectrum of the averaged spatial 
information measuring the backscattered signal through an optical fiber. This will modify the 
table-top PWS system to a compact real-time diagnosis microscopic system. These changes can 
help to develop this system as a commercial product for early, effective, and real-time diagnosis 
of cancer or any other abnormalities in cells/tissue for the future.     
6.3 IPR study conclusions 
We have developed the novel approach based on mesoscopic physics-based light 
localization properties, IPR technique to quantify the nano to submicron scale mass density or 
refractive index fluctuations in a weakly disordered medium using TEM and Confocal imaging. 
The main advantage of the Confocal-IPR technique is that we can probe and quantify a 
molecular-specific spatial mass density structural change. In this work, we mainly use the 
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Confocal-IPR and TEM-IPR techniques to probe nanoscale mass density fluctuations in the 
cells/tissues to study cancer, drug effects, or and brain abnormalities using a mouse model. First, 
the confocal-IPR technique was used to study the effect of probiotics in chronic alcoholic brain 
cells/components targeting it with different dyes/proteins. Interestingly, the IPR result shows that 
the statistical parameter standard deviation of the average IPR, (<IPR(L)>) or the disorder 
strength (Ld) increase in chronic alcohol-treated glial cells and chromatin of mice brain tissues 
while decreasing gradually when treated with probiotics (L. Plantarum) simultaneously. Here, an 
increase in the molecular specific degree of disorder strength (Ld) of chronic alcoholic mice brain 
glial cells, and chromatin might be due to the adverse effect of alcohol in brain cells which 
initially shows effects on the submicron scale quantified by the Confocal-IPR technique. 
Whereas alcoholic brains see an improved cognitive function in the presence of probiotics, L. 
Plantarum, which may help in soothing the brain cell’s structure resulting in decreasing the 
disorder strength (Ld). In conclusion, the reversible effect of probiotics in alcoholic brain 
cells/components could be a useful way to mitigate abnormalities in the brain due to alcohol, 
stress, or any other sedative drugs that need to be explored using this molecular specific light 
localization technique.  
Further, using TEM imaging we can target whole cells or nuclei with ~1nm resolution 
which facilitates the real view of the cell structures at the nanoscale which cannot be performed 
by a standard optical microscope. Thus, with the TEM-IPR technique, the nanoscale mass-
density or refractive index fluctuations in ovarian cancerous cells, as well as anti-cancerous drug 
effects on non-tumor forming OV202NTC and tumor forming OV202Sh1 cells, are quantified. 
Results show an increase in the standard deviation of mass density fluctuations or  
(<IPR(L)>)cells value from non-tumorous NTC to tumorous Sh1 cells while the 
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(<IPR(L)>)cells for two different drugs treated tumorous ovarian cells, Sh1-AACOCF3 and 
Sh1-MAFP, reduces from tumorous cells Sh1 nearly the same to the NTC non-tumorous cells. 
This quantification of the effectiveness of anti-cancerous drugs in ovarian cancer treatment using 
TEM-IPR could enhance better drug treatment modalities at its earliest. Although this study is 
based on ovarian cancer, however, the technique can be applied to the different cancerous cells 
to quantify the effectiveness of different anti-cancerous drugs in cancer treatment. Also, this 
method shows the effectiveness of the developed IPR method at the nanoscale level. Therefore, 
the proposed model is completely based on quantitative analysis and could be the most reliable 
method to study the drug effect in cancer treatment in the future.  
6.4 Future work in IPR and its applications 
The proposed novel approach of mesoscopic physics-based molecular specific light 
localization technique, IPR, using the TEM and confocal images can quantify the nano to 
submicron scale mass density fluctuations and provides numerical means to distinguish cancer, 
drug-effect in cancer treatment, or brain abnormalities. The complication in sample preparation 
and huge instrumentation setup of TEM which can probe samples up to ~1nm shows a potential 
application for the future to quantify the structural properties of different types of cancerous cells 
and the efficacy of drug effect in cancer treatment combining with IPR technique. Also, a further 
improved molecular mass density specific IPR map with a reduced noise could help us locate the 
most affected region in cells with cancer or any other abnormalities. This quantitative IPR 
technique will be more useful to the pathologist who uses stained cells/tissues for cancer 
screening, grade classification, and study drug-effect visualizing constructed IPR images.  
The IPR technique is universal to probe the structural disorder. Initially, it was used for 
cancer diagnosis, however, now we have extended and used it to probe brain abnormalities due 
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to stress, Alzheimer's, or alcohol using confocal imaging. The novel approach of studying 
probiotics' effect in the alcoholic brain where probiotics are used to soothe and increase the 
cognitive function of the brain can be quantified using a confocal-IPR technique for different 
types of commercially available probiotics to understand their effect on the brain cells/tissues. 
This will help to select the right probiotics at their earliest to enhance the cognitive function of 
the alcoholic brain before being too late for treatment, at this clinical research moment. Based on 
the results obtained for alcoholic brain tissue, we can elaborate our study using the confocal-IPR 
technique to study the structural change in brain cells/tissues at the nanoscale level due to stress, 
depression, and Alzheimer's in a mouse model. Recently developed super-resolution microscopy 
has a significant interest in imaging nanoarchitecture which can reach the sensitivity up to 5 nm. 
In the near future, we want to develop an algorithm based on mesoscopic physics-based light 
localization technique to quantify the structural properties in cells/tissues using super-resolution 
microscopy images and compare the obtained result with the existing TEM-IPR and confocal-
IPR results. We believe that this might help us to better understand the structural properties in 
cells/tissue at the nanoscale level. 
In summary, this research presents a key finding that the quantification of spatial 
structural disorder of the weakly disordered medium such as cells/tissues based on mesoscopic 
light transportation and light localization approaches are a promising technique to characterize 
early carcinogenesis, drug-effect, or brain abnormalities. Of course, the main goal of this 
research will direct the improvements in these spectroscopic techniques to use them in a clinical 
setting in a hospital, and further with large-scale clinical trials. At this point, it demands further 
extensive studies in larger sample sizes and clinical trials to achieve the goal of cancer diagnosis 
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B.1 PWS program to calculate disorder strength (Ld) 
clear all 
x_max=1460; %maximum pixel cover in x-axis 
y_max=1920; %maximum pixel cover in y-axis 
fname = 'Name_of_file'; 
info = imfinfo(fname); 
num_images = numel(info); 
for k = 1:num_images % total number of wavelength cover  
     A = imread(fname, k, 'Info', info); 
     for j=1:y_max 
    B(1:x_max,j,k)=A(1:x_max,j); % xyz matric with x,y pixel size of 
camera and z wavelength  
    k %[k j] %[k,i,j, A(j,i)]; 
     end 
end 
      
for i=1:1460 
for j=1:1920 
      kmin=1; 
      kmax=150; 
      xBB=kmin:kmax; 
      yBB1=BB(i,j,kmin:kmax); 
      yBB2=squeeze(yBB1); 
      yBB4=yBB2'; 
    
     [b,a] = butter(15,0.5);  % 6th order polynomial 
     yBB=filter(b,a,yBB4);   % finally extracted reflection data 
     
      yBB=double(yBB4); 
      pfBB=polyfit(xBB,yBB,3); 
      yfBB=polyval(pfBB,xBB); 
      s1=yBB-yfBB; 
      s_srt=sort(s1);    
      s_up= mean(s_srt(1:7)); 
      s2=s1+ abs(s_up); 
       %s2=s1; % 
      %s2=s1+ pfBB(1) + 0.000001; 
      %s2=s1./max(s1); 
      %s2=(smooth(s2))'; 
      
      BBrms(i,j)=rms(s2);  
       
      qmin=kmin+500; % Starting wavelength to cover in nm 
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      qmax=kmax+500; % Ending wavelength to cover in nm 
      q=qmin:qmax; %wavelength region covered 
      kd=(2*pi./q)*1000;  % k vector 
      kd1=floor(length(kd)/2); %mid length of wave vector 
      kdm=kd(kd1); %mid value of wave vector 
      n0=1.38;  %refractive index 
       
       
      xcr=xcorr(s2); 
      y_v=log(xcr(150:154)/xcr(150)); 
      x_v=(1:5)*0.01915; 
      xx_v=x_v.*x_v; 
      ck=polyfit(xx_v,y_v,1); 
      CKm(i,j)=ck(2); 
      % Structural Disorder to be calculated 




























m=4; %sample box size                       % input 
n=m*m; 
n_i_max=250; %total # of boxes in row       % input 
n_j_max=250; %total # of boxes in column    % input  
k=0; 
nf=250;   % histogram division 
for n_az=1:6        
    n_ct=0; 
    
if n_az==1 




















az =imread('d6a.tif');    %input       % change the name of the img 
***************** 
end 
az = double(az); 
az = double(az(1:1000, 1:1000));   % input   (careful about the color)  












hu(k2)= h1(i2+(n_i-1)*m , j2+(n_j-1)*m); 
end 
end 
hu_sum = sum(hu); 
if(hu_sum==0) 
    hu_sum=1; 
end 
hu_N = (hu/hu_sum)*1*length(hu); 









for k=1:n       
   a(k,k)=d1(k,k); 
end%if 
for k=1:n 
     if((k-m)>0) 
     a(k,k-m)=t; 
     a(k-m,k)=t; 
      end 
       
      if((k+m)<=n) 
     a(k,k+m)=t; 
     a(k+m,k)=t; 
      end 
       
      if((k-1)>0) 
     a(k-1,k)=t; 
     a(k,k-1)=t; 
      end 
       
      if((k+1)<=n) 
     a(k+1,k)=t; 
     a(k,k+1)=t; 
      end 
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end %k   
  
[v,d]=eig(a); 










x1av = sum(n1.*x1*(x1(4)-x1(3))); 
%x2av = sum(n2.*x2*(x2(4)-x2(3))) 
%x3av = sum(n3.*x3*(x3(4)-x3(3))) 
 %figure(2) 
 %plot(x1,n1,'-*b')%, x2,n2,'-*m',x3,n3,'-*r') 
% axis([ 1.5 5 0 1000]) 
n_ct=n_ct+1; 
d_sline(n_ct)=x1av;           % all ipr values in one array 







































save d6a.dat d_sline -ascii       % input saved file 
************************** 
end 
figure, imagesc(d_ipr); colormap(jet) 
end 
 
B.3 IPR program to calculate <IPR> using TEM images 
clear all 
n_sample=1; 








%amp=3; %smplificstion modified 
for n_az=1:n_sample       




% if n_az==2 
% az=imread('control_11.tif'); 
% end 





% if n_az==4 
% az=imread('control_18.tif'); 
% end 






 for n_j=1:n_ij_max 






hu(k2)= h1(i2+(n_i-1)*m , j2+(n_j-1)*m); 
end 
end 
hu_sum = sum(hu); 
if(hu_sum==0) 
    hu_sum=1 
end 









for k=1:n    
    a(k,k)=d1(k,k); 
    %a(k,k)=amp*d1(k,k); % amplification modified 
end%if 
for k=1:n 
     if((k-m)>0) 
     a(k,k-m)=t; 
     a(k-m,k)=t; 
      end 
       
      if((k+m)<=n) 
     a(k,k+m)=t; 
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     a(k+m,k)=t; 
      end 
       
      if((k-1)>0) 
     a(k-1,k)=t; 
     a(k,k-1)=t; 
      end 
       
      if((k+1)<=n) 
     a(k+1,k)=t; 
     a(k,k+1)=t; 
      end      
end %k   
  
[v,d]=eig(a); 








x1av = sum(n1.*x1*(x1(4)-x1(3))); 










save c1a.dat d_sline -ascii 
figure(101), hist(d_sline,nf); 
figure(102), imagesc(d_ipr); 
   
  
 
 
 
